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A B S T R A C T
Background
Polycystic ovarian syndrome (PCOS) is characterised by the clinical signs of oligo-amenorrhoea, infertility and hirsutism. Conventional
treatment of PCOS includes a range of oral pharmacological agents, lifestyle changes and surgical modalities. Beta-endorphin is present
in the follicular fluid of both normal and polycystic ovaries. It was demonstrated that the beta-endorphin levels in ovarian follicular
fluid of otherwise healthy women who were undergoing ovulation were much higher than the levels measured in plasma. Given
that acupuncture impacts on beta-endorphin production, which may affect gonadotropin-releasing hormone (GnRH) secretion, it is
postulated that acupuncture may have a role in ovulation induction via increased beta-endorphin production effecting GnRH secretion.
This is an update of our previous review published in 2016.
Objectives
To assess the effectiveness and safety of acupuncture treatment for oligo/anovulatory women with polycystic ovarian syndrome (PCOS)
for both fertility and symptom control.
Search methods
We identified relevant studies from databases including the Gynaecology and Fertility Group Specialised Register, CENTRAL, MED-
LINE, Embase, PsycINFO, CNKI, CBM and VIP. We also searched trial registries and reference lists from relevant papers. CENTRAL,
MEDLINE, Embase, PsycINFO, CNKI and VIP searches are current to May 2018. CBM database search is to November 2015.
Selection criteria
We included randomised controlled trials (RCTs) that studied the efficacy of acupuncture treatment for oligo/anovulatory women with
PCOS. We excluded quasi- or pseudo-RCTs.
Data collection and analysis
Two review authors independently selected the studies, extracted data and assessed risk of bias. We calculated risk ratios (RR), mean
difference (MD), standardised mean difference (SMD) and 95% confidence intervals (CIs). Primary outcomes were live birth rate,
multiple pregnancy rate and ovulation rate, and secondary outcomes were clinical pregnancy rate, restored regular menstruation period,
miscarriage rate and adverse events. We assessed the quality of the evidence using GRADE methods.
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Main results
We included eight RCTs with 1546 women. Five RCTs were included in our previous review and three new RCTs were added in this
update of the review. They compared true acupuncture versus sham acupuncture (three RCTs), true acupuncture versus relaxation (one
RCT), true acupuncture versus clomiphene (one RCT), low-frequency electroacupuncture versus physical exercise or no intervention
(one RCT) and true acupuncture versus Diane-35 (two RCTs). Studies that compared true acupuncture versus Diane-35 did not
measure fertility outcomes as they were focused on symptom control.
Seven of the studies were at high risk of bias in at least one domain.
For true acupuncture versus sham acupuncture, we could not exclude clinically relevant differences in live birth (RR 0.97, 95% CI 0.76
to 1.24; 1 RCT, 926 women; low-quality evidence); multiple pregnancy rate (RR 0.89, 95% CI 0.33 to 2.45; 1 RCT, 926 women; low-
quality evidence); ovulation rate (SMD 0.02, 95% CI -0.15 to 0.19, I2 = 0%; 2 RCTs, 1010 women; low-quality evidence); clinical
pregnancy rate (RR 1.03, 95% CI 0.82 to 1.29; I2 = 0%; 3 RCTs, 1117 women; low-quality evidence) and miscarriage rate (RR 1.10,
95% CI 0.77 to 1.56; 1 RCT, 926 women; low-quality evidence).
Number of intermenstrual days may have improved in participants receiving true acupuncture compared to sham acupuncture (MD -
312.09 days, 95% CI -344.59 to -279.59; 1 RCT, 141 women; low-quality evidence).
True acupuncture probably worsens adverse events compared to sham acupuncture (RR 1.16, 95% CI 1.02 to 1.31; I2 = 0%; 3 RCTs,
1230 women; moderate-quality evidence).
No studies reported data on live birth rate and multiple pregnancy rate for the other comparisons: physical exercise or no intervention,
relaxation and clomiphene. Studies including Diane-35 did not measure fertility outcomes.
We were uncertain whether acupuncture improved ovulation rate (measured by ultrasound three months post treatment) compared to
relaxation (MD 0.35, 95% CI 0.14 to 0.56; 1 RCT, 28 women; very low-quality evidence) or Diane-35 (RR 1.45, 95% CI 0.87 to
2.42; 1 RCT, 58 women; very low-quality evidence).
Overall evidence ranged from very low quality to moderate quality. The main limitations were failure to report important clinical
outcomes and very serious imprecision.
Authors’ conclusions
For true acupuncture versus sham acupuncture we cannot exclude clinically relevant differences in live birth rate, multiple pregnancy
rate, ovulation rate, clinical pregnancy rate or miscarriage. Number of intermenstrual days may improve in participants receiving true
acupuncture compared to sham acupuncture. True acupuncture probably worsens adverse events compared to sham acupuncture.
No studies reported data on live birth rate and multiple pregnancy rate for the other comparisons: physical exercise or no intervention,
relaxation and clomiphene. Studies including Diane-35 did not measure fertility outcomes as the women in these trials did not seek
fertility.
We are uncertain whether acupuncture improves ovulation rate (measured by ultrasound three months post treatment) compared to
relaxation or Diane-35. The other comparisons did not report on this outcome.
Adverse events were recorded in the acupuncture group for the comparisons physical exercise or no intervention, clomiphene and
Diane-35. These included dizziness, nausea and subcutaneous haematoma. Evidence was very low quality with very wide CIs and very
low event rates.
There are only a limited number of RCTs in this area, limiting our ability to determine effectiveness of acupuncture for PCOS.
P L A I N L A N G U A G E S U M M A R Y
Acupuncture for polycystic ovarian syndrome
Review question
What is the effectiveness and safety of acupuncture treatment for ovulation disorders in women with polycystic ovarian syndrome
(PCOS)?
Background
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PCOS is where women have multiple cysts (fluid-filled sacs) on their ovaries (organs that produce eggs) and is characterised by the
clinical signs of infrequent or very light menstruation (periods), failure to conceive (become pregnant) and excessive hair growth.
Women may or may not have symptoms. The current standard western treatments for women with PCOS are prescription medicines,
surgery and lifestyle changes. There has been evidence suggesting acupuncture may influence ovulation (release of the egg) by affecting
levels of various hormones. Acupuncture is a Chinese therapy where fine needles are inserted into the skin in certain places. The exact
mechanism of how acupuncture works for PCOS is not known and we aimed to explore the use of it for PCOS in this review.
Study characteristics
We searched medical databases for clinical studies where people were randomly put into one of two or more treatment groups including
acupuncture treatment for women with PCOS who were infrequently or never ovulating. Acupuncture was compared with pretend
acupuncture (sham), no treatment, lifestyle changes (e.g. relaxation) and conventional treatment.
We included eight studies with 1546 women in this review. The studies compared true acupuncture versus sham acupuncture,
clomiphene (medicines to induce ovulation), relaxation and Diane-35 (combined oral contraceptive pill); and low-frequency elec-
troacupuncture (where small electrical currents are passed through the acupuncture needles) versus physical exercise. We included
women who wanted to get pregnant and women who wanted regular ovulation and symptom control as our two main populations of
interest.
Key results
Our main interests were live birth rate, multiple pregnancy rate (for women who wanted to get pregnant) and ovulation rate (for women
who wanted regular ovulation/symptom control). Due to the very low quality of the evidence and imprecise results, we were uncertain
of the effect of acupuncture on live birth rate, multiple pregnancy rate and ovulation rate compared to sham acupuncture. For the
same reasons, we were also uncertain of the effect of acupuncture on clinical pregnancy and miscarriage rate. Acupuncture may have
improved restoration of regular menstrual periods. Acupuncture probably worsened side effects when compared to sham acupuncture.
No studies reported data on live birth rate and multiple pregnancy rate for the other comparisons: physical exercise or no intervention,
relaxation and clomiphene. Studies including Diane-35 did not measure fertility outcomes as women were only interested in symptom
control.
We were uncertain whether acupuncture improved ovulation rate compared to relaxation or Diane-35 (measured by ultrasound, which
uses high-frequency sound waves to create an image, three months after treatment). The other comparisons did not report on ovulation
rate.
Side effects were recorded in the acupuncture group for the comparisons physical exercise or no intervention, clomiphene and Diane-
35. These included dizziness, nausea (feeling sick) and bruising.
The overall evidence was low or very low reliability. There is currently insufficient evidence to support the use of acupuncture for
treatment of ovulation disorders in women with PCOS.
Reliability of the evidence
The evidence ranged from very low to moderate reliability, the main limitations were not reporting important clinical results and not
enough data.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
True acupuncture compared to sham acupuncture for polycystic ovarian syndrome
Patient or population: polycyst ic ovarian syndrome
Setting: outpat ient
Intervention: t rue acupuncture
Comparison: sham acupuncture




Quality of the evidence
(GRADE)
Risk with sham acupunc-
ture
Risk with true acupuncture






224 per 1000 218 per 1000
(171 to 278)






17 per 1000 15 per 1000
(6 to 42)
Ovulation rate The mean ovulat ion rate
was 0
SMD 0.02 higher















The mean restored regular
menstrual period was 0
MD 312.09 days lower




































































































113 per 1000 125 per 1000
(87 to 177)






400 per 1000 464 per 1000
(408 to 524)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; MD: mean dif ference; RCT: randomised controlled trial; RR: risk rat io; SMD: standardised mean dif ference.
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for high risk of detect ion bias in one study.
bDowngraded one level for imprecision - single study and conf idence intervals compatible with benef it in either arm or no
ef fect.
cDowngraded one level for high risk of performance bias in one study.
dDowngraded one level for imprecision - conf idence intervals compatible with benef it in either arm or no ef fect.
eDowngraded one level for high risk of attrit ion bias and detect ion bias in two studies.

























































































B A C K G R O U N D
Description of the condition
Polycystic ovarian syndrome (PCOS) is characterised by the clin-
ical signs of oligo-amenorrhoea (infrequent or very light men-
struation), infertility (failure to conceive) and hirsutism (excessive
hair growth). Biochemically, women with PCOS often show signs
of hyperandrogenism (excessive production of androgen). They
often have anovulatory infertility (failure to conceive due to no
ovulation), and metabolic disorders (e.g. diabetes mellitus) (Wild
2000). In addition, PCOS can have substantial implications on a
woman’s psychological well-being across the entire lifespan (Teede
2010). PCOS has become a major healthcare issue that deserves
an increase in focus, from both clinical and public health perspec-
tives.
Clinically, PCOS is one of the most common endocrine con-
ditions seen in gynaecology and general endocrinology practice
(Norman 2004). The diagnostic criteria for PCOS that we applied
in this review were based on the Rotterdam Criteria established by
the European Society of Human Reproduction and Embryology
(ESHRE) and the American Society of Reproductive Medicine
(ASRM) consensus in Rotterdam, 2003 (ESHRE/ASRM 2004).
Any woman with at least two of the following three criteria were
considered to have PCOS: ovulatory dysfunction (oligo- or anovu-
lation), hyperandrogenaemia or polycystic ovaries on ultrasound
evaluation; after the exclusion of other aetiologies of hyperandro-
genism (excessive production of androgens such as androgen-se-
creting tumours, hyperprolactinaemia, dysthyroid disease, Cush-
ing’s syndrome and congenital adrenal cortical hyperplasia).
In 2012, the prevalence rate of PCOS was between 6% and 10%
based on the National Institute of Health criteria and was as high
as 15% based on the Rotterdam criteria (Fauser 2012). Limited
data are available regarding prevalence of this condition in Aus-
tralia. One south Australian survey identified that 12% to 18%
of women of reproductive age were affected (March 2010). Na-
tional differences in prevalence rates exist, for example, one study
showed a rate of 26% in the UK (Michelmore 1999). Results from
these surveys are dependent on the protocol used. If the US cri-
teria that do not consider ovarian morphology were adopted, the
prevalence rate ranged from 4.5% to 11.2% from an unselected
group of white and black Americans in a population-based study
in Alabama (Knochenhauer 1998). There was a prevalence rate of
9% in Greece (Diamanti-Kandarakis 1999), and 6.5% in Spain
(Asunicón 2000). The highest reported prevalence of PCOS was
52% among South Asian immigrants in the UK, of whom 49.1%
had menstrual irregularities (Rodin 1998).
In traditional Chinese medicine, all diseases are classified into dif-
ferent syndromes (e.g. deficiency or excess) according to the per-
son’s clinical presentations (signs and symptoms). It is believed
that kidney deficiency is the major concern relating to the repro-
ductive function of women with PCOS (Ni 2007; Wang 2008).
Description of the intervention
Body acupuncture and ear acupuncture have been used as treat-
ments for oligo/anovulatory women with PCOS. Body acupunc-
ture involves stimulation of body acupuncture points through
body needling using different sized sterile needles; while ear
acupuncture involves points on the external ears that are stimu-
lated either by needles or pellets. In randomised controlled tri-
als (RCTs) of acupuncture, sham acupuncture is also known as
placebo acupuncture. However, how sham acupuncture should
be performed still remains controversial and can be different
from study to study. The general principle of administering sham
acupuncture is not to stimulate the actual acupuncture point with
needles or electrostimulation.
Electroacupuncture is also known as electrostimulation. It is per-
formed using stimulation with electrical impulses of acupuncture
needles on selected acupuncture points.
Acupuncture is known to be a safe treatment. Transient adverse
effects, such as skin erythema, bruising, bleeding and pain, are
uncommon. Reports of significant complications are exceedingly
rare. One observational study including more than 200,000 partic-
ipants who received acupuncture for pain found an adverse event
rate of 8.6% (Witt 2009). Another similar study estimated that
the serious adverse event rate was between 0 and 1.1 per 10,000
treatments (MacPherson 2001).
Currently the first-line pharmacological therapy for anovulatory
infertility in women with PCOS is the administration of oral se-
lective oestrogen receptor modulator such as clomiphene (Teede
2011). However, up to 40% of affected women show little clini-
cal improvement with clomiphene therapy (Brown 2009). Other
agents, such as insulin sensitisers, are used. This is based on the hy-
pothesis that increasing insulin sensitivity reduces serum androgen
levels thus improving fertility (Acbay 1996). Evidence suggests that
metformin offers some improvement beyond clomiphene ther-
apy (Tang 2012). Women resistant to these therapies can be fur-
ther trialled on exogenous gonadotrophin preparations (ESHRE
1997). Alternatively, surgical options, such as laparoscopic ovarian
drilling, can be explored (Gadir 1990). Women who respond to
clomiphene therapy have higher risks of ovarian hyperstimulation
syndrome and multiple pregnancy (Farhi 1996). Combined oral
contraceptive pills such as Diane-35 (ethinylestradiol and cypro-
terone acetate) are also used in women with PCOS to achieve
symptom control. Oestrogen increases sex hormone binding glob-
ulin (SHBG) while progestin suppress luteinising hormone (LH)
levels resulting in decreased production of androgen by the ovaries
and decreased bioavailable androgen. This results in improvement
in symptoms including hirsutism, acne and menstrual irregular-
ity seen in women with PCOS. Thus, oral contraceptives are rec-
ommended as first-line therapy for hirsutism, acne and menstrual
abnormalities in women with PCOS (Legro 2013).
In recent years there has been extensive interest into non-steroidal
aromatase inhibitors such as letrozole. In anovulatory women, aro-
matase inhibitors downregulate oestrogen biosynthesis and reduce
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negative feedback to the hypothalamus, which leads to stronger
gonadotropin-releasing hormone (GnRH) pulses (Franik 2018).
One Cochrane Review suggested a significant efficacy advantage to
clomiphene, despite low to moderate quality of evidence (Franik
2018). Aromatase inhibitors are also free from adverse effects asso-
ciated with antioestrogenic effects in the endometrium and cervix.
Nevertheless, currently, use of such therapy is limited by low qual-
ity of supportive evidence.
How the intervention might work
Scientific studies have investigated the acupuncture meridians and
the neuroendocrinological aspects of the meridians. Mayer 1977
proposed that acupuncture may stimulate the production of en-
dorphin, an effect antagonised (counteracted) by the narcotic an-
tagonist naloxone, in order to provide an analgesic effect. Ku 2001,
Petti 1998, and Ulett 1998 have carried out further research in this
area and postulated that beta-endorphin and various neuropep-
tides (e.g. protein pro-opiomelanocortin) within the nervous sys-
tem may be implicated in producing the effects of acupuncture.
Aleem 1987 identified the presence of beta-endorphin in the fol-
licular fluid from both normal and polycystic ovaries. Petraglia
1987 demonstrated that the beta-endorphin levels in ovarian fol-
licular fluid of otherwise healthy women who were undergoing
ovulation were much higher than the levels measured in plasma.
Studies have shown that acupuncture decreases cortisol concentra-
tions and modulates central and peripheral beta-endorphin pro-
duction and secretion, influencing the release of GnRH and go-
nadotrophin (Stener-Victorin 2007). Different non-randomised
preliminary observational studies have shown that acupuncture
may normalise the production of LH and follicle-stimulating hor-
mone (FSH) (Aso 1976; Cai 1997; Mo 1993). Chen 1991 con-
sidered that electroacupuncture has a role in normalising the hy-
pothalamic-pituitary ovarian axis, which in turn affects the men-
struation cycle pattern. Clinically, the selection of acupuncture
points is based on traditional Chinese medicine principles and can
be variable.
Gerhard 1992 (in a case series) used ear acupuncture on 45 infer-
tile women with dysfunction of ovulation and compared the treat-
ment group with women receiving conventional medical treat-
ment (e.g. dexamethasone, clomiphene citrate and gonadotropin).
They concluded that the rate of return of menstruation was com-
paratively better in the ear acupuncture group despite no differ-
ence between the two groups on pregnancy rates.
Stener-Victorin 2000 (in a case series) investigated its efficacy on
ovulation induction in women with PCOS. Although the sam-
ple size was small (24 participants), two-thirds of the women in
the study reported a regular menstruation pattern for up to three
months after cessation of the electroacupuncture treatment.
Why it is important to do this review
Women with PCOS seek both fertility and symptom control
such as irregular menstrual cycles, amenorrhoea, insulin resistance,
polycystic ovaries, androgen disturbance, hirsutism, acne, or a
combination of these. Currently the main forms of treatment for
women with PCOS are pharmacological-based therapies such as
clomiphene for fertility and the combined oral contraceptive pill
for symptoms control (e.g. irregular menstrual cycles). However,
pharmacological-based therapies are also associated with different
adverse effects.
Acupuncture is growing in popularity among western countries.
Xue 2007 reported that 68.9% of the Australian population are
users of complementary and alternative medicine, while 9.2% of
the Australian population have used acupuncture according to a
national population-based survey performed in 2005. In the UK,
a steady increase over time in the utilisation of acupuncture was
reported from 3 million per year in 2001 to about 4 million in
2012 (Hopton 2012; Thomas 2001). In the USA, the number of
acupuncture users increased by 50% over the 10-year period from
2002 to 2012 (Cui 2017).
Previously there was uncertainty regarding the efficacy of acupunc-
ture for oligo/anovulatory women with PCOS due to absence of
RCTs and systematic reviews. This present review will contribute
to the clinical knowledge in this area by summarising currently
available knowledge. From a clinical point of view, the manage-
ment of PCOS has been an evolving area where current paradigms
were continuously challenged with novel modalities. This review
aimed to address both women with PCOS who seek fertility and
those that seek symptom control. This is an update of a Cochrane
Review first published in 2011, which aimed to provide an objec-
tive basis for healthcare practitioners to recommend acupuncture
treatment for women where complementary therapy may be ap-
propriate.
O B J E C T I V E S
To assess the effectiveness and safety of acupuncture treatment
for oligo/anovulatory women with polycystic ovarian syndrome
(PCOS) for both fertility and symptom control.
M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs studying the efficacy of acupuncture treatment for oligo/
anovulation in women with PCOS. We excluded quasi-, pseudo-
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or non-RCTs. We excluded cross-over trials unless first-phase data
were available.
Types of participants
Women of reproductive age (18 to 44 years) with PCOS and oligo/
anovulation. We included both women who sought fertility and
those that sought symptom control.
The diagnostic criteria of PCOS applied in this review were based
on the ESHRE and ASRM consensus in Rotterdam in 2003
(ESHRE/ASRM 2004). We considered any woman with any two
of the three listed criteria as having PCOS. After the exclusion of
other aetiologies of hyperandrogenism (such as androgen-secret-
ing tumour, hyperprolactinaemia, dysthyroid disease, Cushing’s
syndrome and congenital adrenal cortical hyperplasia), these were
the presence of:
• oligo or anovulation;
• hyperandrogenaemia or
• polycystic ovaries.
Ideally the diagnostic criteria for PCOS should have been stated
and described in trials selected for this review. If the trials did not
use the Rotterdam consensus, the review authors evaluated the di-
agnostic criteria for each individual study to confirm whether they
met the Rotterdam consensus. If the diagnostic criteria were not
clearly stated, we contacted the trial authors to obtain clarifica-
tion. Where clarification was not available, we excluded the trials.
Differences in diagnostic criteria may produce variability in the
clinical characteristics of the women included and the results ob-
tained. We had planned to consider, document and explore these
changes in a sensitivity analysis.
Types of interventions
Acupuncture, including body needling and low-frequency elec-
troacupuncture, was the main intervention.
Eligible comparators were placebo, no intervention, lifestyle in-
tervention and conventional treatment of PCOS (e.g. clomiphene
citrate).
Sham acupuncture is also known as placebo acupuncture and uses
techniques that are not intended to stimulate known acupuncture
points. Normally it is used for the control group in a RCTs of
acupuncture.
We excluded clinical trials using Chinese herbal medicine for the
management of PCOS from this review because it is assessed in
another Cochrane Review (Zhang 2010). We also excluded clini-
cal trials that included ovarian wedge resection as the control in-
tervention because this method is no longer applied by surgeons
since the development of laparoscopic ovarian drilling.
Types of outcome measures
Primary outcomes
• Live birth rate (defined as delivery of live foetus after 20
completed weeks of gestation) - for women seeking fertility.
• Multiple pregnancy rate (defined as more than one
intrauterine pregnancy) - for women seeking fertility.
• Ovulation rate (as determined by ultrasound or increased
progesterone) - for women seeking symptom control.
Secondary outcomes
• Clinical pregnancy rate (defined as evidence of gestational
sac or foetal heart motion, confirmed with ultrasound).
• Restored regular menstrual period (as defined by study
authors, including rate or continuous measurements).
• Miscarriage rate (loss of intrauterine pregnancy before 20
completed weeks of gestation).
• Adverse events (as defined by study authors).
Search methods for identification of studies
We developed a comprehensive search strategy to identify all RCTs
regardless of language or publication status (published, unpub-
lished, in press or in progress).
Electronic searches
We identified relevant studies from:
• the Gynaecology and Fertility Group Specialised Register
(searched 22 May 2018);
• CENTRAL via the Cochrane Central Register of Studies
Online (CRSO) (searched 22 May 2018);
• Ovid MEDLINE (searched from 1946 to 22 May 2018);
• Ovid Embase (searched from 1980 to 22 May 2018);
• Ovid PsycINFO (searched from 1806 to 22 May 2018);
• Ovid AMED (searched from 1985 to 22 May 2018);
• Chinese National Knowledge Infrastructure (CNKI;
including the Chinese journal full-text database (CJFD), China’s
important Conference Papers Database and China dissertation
database) (searched from 2010 to 24 May 2018);
• Chinese BioMedical Literature Database (CBM) (searched
from 2010 to 21 November 2015);
• VIP database for Chinese Technical Periodicals (searched
from 2010 to 24 May 2018).
We combined the MEDLINE search with the Cochrane highly
sensitive search strategy for identifying randomised trials, which
appears in Chapter 6 of the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011). We combined the Em-
base search with trial filters developed by the Scottish Inter-
collegiate Guidelines Network (SIGN) ( www.sign.ac.uk/search-
filters.html).
We constructed search strategies by using a combination of subject
headings and text words relating to the use of acupuncture for
the management of PCOS (Appendix 1; Appendix 2; Appendix
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3; Appendix 4; Appendix 5; Appendix 6; Appendix 7; Appendix
8; Appendix 9). All the terms were translated into Chinese for
the searches in Chinese databases to be conducted. There was no
language restriction in these searches.
We searched trial registers for ongoing and registered trials on
22 May 2018: ClinicalTrials.gov, a service of the US National
Institutes of Health ( clinicaltrials.gov/ct2/home); the World
Health Organization International Trials Registry Platform search
portal ( www.who.int/trialsearch/Default.aspx); the Australian
and New Zealand Clinical Trial Registry ( www.anzctr.org.au/
Default.aspx) (Appendix 10); and Chinese Clinical Trial Registry
( www.chictr.org.cn/).
Searching other resources
We checked the reference lists of relevant trials, reviews and text-
books.
Data collection and analysis
Selection of studies
In this update, two review authors (RN, GZ) performed the
searches and retrieved the articles. We retrieved and reviewed all
studies that claimed to be randomised and had not already been
reviewed as part of earlier versions of this review. We judged tri-
als as adequately randomised if they met the set criteria (Higgins
2011).
Data extraction and management
In this update, two review authors (RN, GZ) independently ex-
tracted data using a piloted data extraction form, which included
details of methods, participants, interventions and outcomes. All
studies were then assessed independently and any dispute was re-
solved by a third independent review author (HC).
Assessment of risk of bias in included studies
We assessed the methodological quality using the six domains de-
scribed in Cochrane’s tool for assessing risk of bias (Figure 1; Figure
2):
Figure 1. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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• sequence generation;
• allocation concealment;
• blinding of participants and personnel;
• blinding of outcome assessment;
• incomplete outcome data;
• selective outcome reporting;
• other sources of bias.
Measures of treatment effect
We used risk ratio (RR) to measure binary outcomes. For con-
tinuous outcomes, we used mean difference (MD) if the studies
used same measurement scales. If studies used different scales, we
used the standardised mean difference (SMD). We calculated 95%
confidence intervals (CI) for all outcomes.
Unit of analysis issues
The unit of analysis was the woman for all outcomes.
Dealing with missing data
We analysed the data on an intention-to-treat (ITT) basis as far
as possible (i.e. including all randomised participants in analysis,
in the groups to which they were randomised). Where data were
not obtainable, we analysed only the available data.
Assessment of heterogeneity
We assessed heterogeneity using the Chi2 test (with a 10% level
of statistical significance). We planned to use the I2 statistic to
estimate the total variation across studies, with less than 25% con-
sidered as low-level heterogeneity; 25% to 50% as moderate level
and greater than 50% as a high level of heterogeneity (Higgins
2002). In addition, we scanned forest plots visually for evidence
of heterogeneity (non-overlapping CIs). We planned further in-
vestigation such as subgroup analysis to be carried out to consider
possible causes of any heterogeneity. In addition, we planned to
use a random-effects model if statistical heterogeneity was evident
from the formal tests.
Assessment of reporting biases
We planned to assess publication bias using a funnel plot, if there
were sufficient studies (at least 10) in one analysis.
Data synthesis
If the studies were sufficiently similar, we combined the data using
a fixed-effect model. Comparisons included in this review were:
• true acupuncture versus sham acupuncture;
• low-frequency electroacupuncture versus physical exercise
or no intervention;
• true acupuncture versus lifestyle intervention (relaxation);
• true acupuncture versus conventional treatment
(clomiphene);
• true acupuncture versus conventional treatment (Diane-
35).
Subgroup analysis and investigation of heterogeneity
If there is a sufficient number of RCTs for inclusion in the review
in future updates, we plan to conduct a subgroup analysis to ex-
plore sources of heterogeneity. We plan to base subgroups on dif-
ferences observed, for example, content of acupuncture prescrip-
tion or clinical differences between participants.
Sensitivity analysis
We planned to conduct sensitivity analyses for the primary out-
comes to determine whether the conclusions were robust to arbi-
trary decisions made regarding the eligibility and analysis. These
analyses included consideration of whether the review conclusions
would have differed if:
• eligibility had been restricted to studies at low risk of bias,
defined as studies at low risk of selection bias and not at high risk
of bias in any domain;
• a fixed-effect model had been adopted;
• alternative imputation strategies had been implemented;
• the summary effect measure had been RR rather than odds
ratio.
Sensitivity analyses was not conducted for this review due to in-
sufficient number of studies.
Quality of the evidence: ’Summary of findings’ table
We presented ’Summary of findings tables’ using GRADEpro and
Cochrane methods. One table evaluated the overall quality of the
body of evidence for the main review outcomes (live birth rate,
multiple pregnancy rate, ovulation rate, clinical pregnancy rate,
restored regular menstrual period, miscarriage rate and adverse
events) for the main review comparison (true acupuncture com-
pared to sham acupuncture).
Additional ’Summary of findings’ tables were prepared for the
main review outcomes for other important comparisons (low-
frequency electroacupuncture compared to physical exercise or
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no intervention, true acupuncture compared to relaxation, true
acupuncture compared to clomiphene, and true acupuncture com-
pared to Diane-35). We assessed the quality of the evidence using
GRADE criteria: risk of bias, consistency of effect, imprecision, in-
directness and publication bias). Two review authors (RN, GZ) in-
dependently made judgements about evidence quality (high, mod-
erate, low or very low) and resolved disagreements by discussion.
Judgements were justified, documented and incorporated into re-
porting of results for each outcome. We extracted study data, for-
matted our comparisons in data tables and prepared ’Summary of
findings’ tables before writing the results and conclusions of our
review.
R E S U L T S
Description of studies
Results of the search
The initial search combined with the new updated search iden-
tified 1263 articles from databases and registers specified in the
Methods section. After screening and removal of duplicates, we as-
sessed 44 full-text articles for eligibility. We excluded other articles
on the basis of their titles or abstracts because they did not meet
the inclusion criteria. After screening the full text of the selected
articles, 13 articles met the inclusion criteria. Five RCTs were in-
cluded in our previous review (Du 2011; Jedel 2011; Johansson
2013; Lim 2014; Pastore 2011). Three new studies (seven articles)
were included in this version of the review (Cao 2017; Jin 2016;
Wu 2017). Five articles were publications relating to the same
study (Wu 2017). Thus, we included eight RCTs in this review
(Figure 3).
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Figure 3. Study flow diagram. PCOS: polycystic ovarian syndrome.
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Included studies
See Characteristics of included studies table.
Study design
We included eight RCTs in this review. One multicentre, two-
arm parallel study was conducted in Australia and China (Lim
2014); one single-centre, three-arm parallel study was conducted
in Sweden (Jedel 2011); one single-centre, two-arm parallel study
was conducted in the US (Pastore 2011); three single-centre, two-
arm parallel studies conducted in China (Cao 2017; Du 2011; Jin
2016), one single-centre, two-arm parallel trial was conducted in
Sweden (Johansson 2013), and one multicentre, 2 × 2 factorial
trial was conducted in China (Wu 2017).
Participants
The trials included 1546 women with PCOS. This included
1418 women who were seeking fertility (Du 2011; Jedel 2011;
Johansson 2013; Lim 2014; Pastore 2011; Wu 2017), and 128
women who were seeking symptom control (Cao 2017; Jin 2016).
Cao 2017 included 56 participants; Du 2011 included 60 partic-
ipants; Jedel 2011 included 84 participants; Jin 2016 included 72
participants; Johansson 2013 included 32 participants; Lim 2014
included 146 participants; Pastore 2011 included 96 participants;
and Wu 2017 included 1000 participants. All participants had a
diagnosis of PCOS made on the basis of Rotterdam consensus,
which included either ultrasound or presence of oligo-amenor-
rhoea and hyperandrogenism, or both. Two studies included addi-
tional diagnoses based on Chinese medicine principles (Du 2011;
Lim 2014).
The main inclusion criteria were:
• ultrasound-verified polycystic ovaries with 10 or 12 follicles
of 2 mm to 9 mm or an ovarian volume of 10 mL in one or both
ovaries, or both (Cao 2017; Du 2011; Jedel 2011; Jin 2016;
Johansson 2013; Lim 2014; Wu 2017);
• presence of oligo-amenorrhoea and hyperandrogenism
(Cao 2017; Du 2011; Jedel 2011; Jin 2016; Lim 2014; Pastore
2011; Wu 2017);
• kidney yang deficiency syndrome as per Chinese medicine
diagnosis (Lim 2014);
• traditional Chinese medicine diagnosis of menstrual
irregularity, amenorrhoea and infertility (Du 2011).
The main exclusion criteria were:
• any pharmacological treatment including Chinese herbal
prescriptions or breastfeeding in period prior to entering study
(Cao 2017; Jedel 2011; Jin 2016; Johansson 2013; Lim 2014;
Wu 2017);
• diabetes mellitus, and endocrine or neoplastic causes of
hyperandrogenaemia, including Cushing’s syndrome, congenital
adrenal hyperplasia and hyperprolactinaemia (Cao 2017; Du
2011; Jedel 2011; Jin 2016; Johansson 2013; Pastore 2011; Wu
2017);
• aged below 18 years (Cao 2017; Jin 2016; Lim 2014), or
above 35 years (Jin 2016); above 38 years (Johansson 2013); or
above 45 years (Cao 2017).
• abnormal full blood count, renal or liver function tests (Cao
2017; Jin 2016; Lim 2014);
• pregnancy within the past six weeks or within six weeks
postabortion or postpartum (Wu 2017).
There were no significant differences between baseline character-
istics of all studies (Cao 2017; Du 2011; Jedel 2011; Jin 2016;
Johansson 2013; Lim 2014; Pastore 2011; Wu 2017).
Interventions
Five studies compared true acupuncture versus sham acupunc-
ture (Cao 2017; Jin 2016; Johansson 2013; Lim 2014; Pastore
2011; Wu 2017). Jin 2016, Johansson 2013, Pastore 2011, Cao
2017, and Wu 2017 used a combination of manual stimulation
and low-frequency electroacupuncture at specified acupuncture
points in the intervention group. Lim 2014 used body needling
with manual stimulation only. Two different sets of acupuncture
points were used alternately in Johansson 2013 and Wu 2017. In
Johansson 2013, participants allocated to the control group re-
ceived relaxation sessions of equal length with the same therapist.
Wu 2017 was a 2 × 2 factorial study that used clomiphene citrate
as the second main intervention. Participants were therefore allo-
cated to active acupuncture plus clomiphene, active acupuncture
plus placebo, control acupuncture plus clomiphene and control
acupuncture plus placebo. Participants who received clomiphene
and placebo were pooled in both arms of the meta-analysis.
One study assessed low-frequency electroacupuncture and phys-
ical exercise (Jedel 2011). Women in the acupuncture interven-
tion group met regularly with researchers to receive treatment and
women who received physical exercise only met once with re-
searchers and received weekly telephone calls. There was a third
arm to this study of no active intervention where women received
telephone information only.
One study compared acupuncture with conventional treatment
with clomiphene (Du 2011). In this study, the acupuncture group
received three cycles of the monthly acupuncture regimen. The
comparison group received clomiphene 50 mg daily for five days.
In both groups, treatment was given on the fifth day after begin-
ning of menstruation. In the case of amenorrhoea, progesterone
was used to induce withdrawal bleeding before treatment was given
in either group.
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Two studies compared acupuncture versus Diane-35 (ethinylestra-
diol and cyproterone acetate tablets) (Cao 2017; Jin 2016). In Cao
2017, the acupuncture group received continuous twice weekly
acupuncture treatment for 12 weeks; while in Jin 2016, the treat-
ments were given three times weekly for three months. The com-
parison group received three cycles of Diane-35, one tablet daily
for 21 days and a seven-day break. Both groups received treatment





One study reported live birth rates (Wu 2017).
Multiple pregnancy rate
One study reported multiple pregnancy rate (Wu 2017).
Ovulation rate
Five studies reported ovulation rate (Du 2011; Jin 2016; Johansson
2013; Pastore 2011; Wu 2017).
Secondary outcomes
Clinical pregnancy rate
Three studies reported clinical pregnancy rate (Lim 2014; Pastore
2011; Wu 2017). Ascertainment of pregnancy was by participant
self-report in Lim 2014 and Pastore 2011. One trial measured
serum human chorionic gonadotropin concentration and con-
firmed pregnancy with pelvic ultrasound (Wu 2017).
Restored regular menstrual period
Five studies reported restored regular menstrual period (Cao 2017;
Du 2011; Jedel 2011; Jin 2016; Lim 2014).
Miscarriage rate
One study reported miscarriage rate (Wu 2017).
Adverse events
Six studies reported adverse events secondary to treatment (Cao
2017; Du 2011; Jedel 2011; Jin 2016; Pastore 2011; Wu 2017).
The other studies did not report adverse events (Johansson 2013;
Lim 2014).
Excluded studies
We excluded 31 studies after evaluation of the full-text articles.
See Characteristics of excluded studies table.
Risk of bias in included studies
Allocation
Sequence generation
All studies described adequate methods of randomisation (com-
puter generated) and were at low risk of bias (Cao 2017; Du 2011;
Jedel 2011; Jin 2016; Johansson 2013; Lim 2014; Pastore 2011;
Wu 2017).
Allocation concealment
Johansson 2013, Jin 2016, and Cao 2017 did not describe al-
location concealment and were at unclear risk of bias. Du 2011
concealed allocation in opaque envelopes that were distributed se-
quentially and was at low risk of bias. The other four studies were
at low risk of bias as they adequately described method of con-
cealment including use of sealed, opaque envelopes (Lim 2014;
Pastore 2011), preprinted barcode labels (Wu 2017), or conceal-
ing until interventions were assigned (Jedel 2011).
Blinding
Blinding of participants and personnel (performance bias)
Pastore 2011 reported blinding of the participants and principal
investigator (low risk of bias). Wu 2017 reported blinding of par-
ticipants in the acupuncture arm and blinding of participants and
study investigators in the clomiphene and placebo group (low risk
of bias).
Lim 2014 reported blinding of participants only (unclear risk of
bias).
Cao 2017, Du 2011, Jedel 2011, and Jin 2016 did not report any
blinding methods (high risk of bias).
Johansson 2013 did not blind participants or therapists in the
study due to the nature of the intervention and the control in the
study (high risk of bias).
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Blinding of outcome assessment (detection bias)
Cao 2017, Du 2011, Jedel 2011, Jin 2016, and Wu 2017 did not
report any blinding methods used (high risk of bias).
Johansson 2013 reported biological outcomes were measured at
an independent laboratory and investigators were blinding until
statistical analyses; however, it was unclear if investigators were
blinded during statistical analyses (unclear risk of bias).
Outcome assessment was completed by statisticians independent
to the study in Lim 2014 (low risk of bias).
Pastore 2011 reported blinding of clinical research co-ordinator
and biostatistician (low risk of bias).
Incomplete outcome data
Eleven of 96 women dropped out during the intervention phase
in Pastore 2011 with no age, education, body-mass index (BMI)
or race difference between the dropouts and the remainder of the
cohort. One woman entered menopausal transition during the
trial and was also excluded. The trial did not report number of
women lost to follow-up. There was no ITT analysis (high risk of
bias).
Lim 2014 excluded four out of 146 women between enrolment
and randomisation phase. There were no dropouts during inter-
vention phase reported. They reported reasons for excluding the
women (low risk of bias).
Jedel 2011 reported 10 dropouts between allocation and baseline
assessments, 15 between baseline and week 16 and nine between
weeks 16 and 32. They conducted an ITT analysis on the 74
participants who went through baseline assessments. They did not
report a comparison of baseline characteristics of dropouts and
women remaining in the trial (unclear risk of bas).
Johansson 2013 reported five dropouts after randomisation. In the
active treatment arm, four women were excluded before baseline
assessment and one woman was lost before final assessment. ITT
analysis was performed of 12 women from the treatment arm and
all 16 women from the control arm. The authors described reasons
for dropouts adequately in the published reports (low risk of bias).
Du 2011 reported that all participants completed the study (low
risk of bias).
Four women out of 56 dropped out during the intervention phase
in Cao 2017, and four out of 72 dropped out during the inter-
vention phase in Jin 2016. The difference between age, BMI or
clinical feature of the dropouts and the remainder of the cohort
was not performed. There was no ITT analysis (high risk of bias).
Wu 2017 reported four participants who conceived after ran-
domisation and before intervention commenced. These women
completed the last visit and were included in the primary analy-
sis. During the intervention phase, 74 participants dropped out
from the study. Fifteen participants dropped out from the active
acupuncture and clomiphene arm; 14 participants dropped out
from the control acupuncture and clomiphene arm; 27 partici-
pants dropped out from the active acupuncture and placebo arm
and 18 participants dropped out from the control acupuncture
and placebo arm. Out of the 14 participants who dropped out
from the control acupuncture and clomiphene arm, two were due
to intervention adverse effects. Out of the 27 participants who
dropped out from the active acupuncture and placebo arm, three
were due to intervention adverse effects. There was no ITT analy-
sis. The authors described reasons for dropouts adequately in the
published reports (unclear risk of bias).
Selective reporting
Two studies did not report adverse events in their published reports
and were at unclear risk of bias (Johansson 2013; Lim 2014). Du
2011 did not report the number of women who had no ovulation
during treatment period (high risk of bias). The remaining studies
reported all listed outcomes (low risk of bias).
Other potential sources of bias
We identified no other potential sources of bias in four studies (Cao
2017; Jedel 2011; Johansson 2013; Lim 2014; Pastore 2011). Jin
2016 and Du 2011 are both unpublished studies from thesis. We
graded them at high risk of bias for possible lack of adequate peer
review. Wu 2017 was supported by various government and non-
government grants. One author in the study reported conflict of
interest due to grant funding. They reported that funding agencies
had no role in the design or conduct of the study (low risk of bias).
Effects of interventions
See: Summary of findings for the main comparison True
acupuncture compared to sham acupuncture for polycystic
ovarian syndrome; Summary of findings 2 Low-frequency
electroacupuncture compared to physical exercise or no
intervention for polycystic ovarian syndrome; Summary of
findings 3 True acupuncture compared to relaxation for polycystic
ovarian syndrome; Summary of findings 4 True acupuncture
compared to clomiphene for polycystic ovarian syndrome;
Summary of findings 5 True acupuncture compared to Diane-35
for polycystic ovarian syndrome
We examined two populations in this review - women seeking
fertility (comparisons 1, 2, 3 and 4) and women seeking symp-
tom control (comparison 5 True acupuncture versus conventional
treatment Diane-35).
1 True acupuncture versus sham acupuncture
Three studies compared true acupuncture versus sham acupunc-
ture (Lim 2014; Pastore 2011; Wu 2017).
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Primary outcomes
Live birth rate
For true acupuncture versus sham acupuncture, we could not ex-
clude clinically relevant differences in live birth (RR 0.97, 95% CI
0.76 to 1.24; 1 RCT, 926 women; low-quality evidence; Analysis
1.1; Wu 2017). This means, low-quality evidence suggested that
if 22% of women achieved live birth with sham acupuncture, be-
tween 17% and 28% would achieve live birth with true acupunc-
ture.
Multiple pregnancy rate
For true acupuncture versus sham acupuncture, we could not ex-
clude clinically relevant differences in multiple pregnancy rate (RR
0.89, 95% CI 0.33 to 2.45; 1 RCT, 926 women; low-quality evi-
dence; Analysis 1.2; Wu 2017). This means, low-quality evidence
suggested that if 2% of women achieved multiple pregnancy with
sham acupuncture, between 0.6% and 4% would achieve multiple
pregnancy with true acupuncture.
Ovulation rate
For true acupuncture versus sham acupuncture, we could not ex-
clude clinically relevant differences in ovulation rate (SMD 0.02,
95% CI -0.15 to 0.19; I2 = 0%; 2 RCTs, 1010 women; low-qual-
ity evidence; Analysis 1.3; Figure 4; Pastore 2011; Wu 2017).




For true acupuncture versus sham acupuncture, we could not ex-
clude clinically relevant differences in clinical pregnancy rate (RR
1.03, 95% CI 0.82 to 1.29; I2 = 0%; 3 RCTs, 1117 women; low-
quality evidence; Analysis 1.4; Figure 5; Lim 2014; Pastore 2011;
Wu 2017). This means, low-quality evidence suggested that if 21%
of women achieved clinical pregnancy with sham acupuncture,
between 17% and 27% would achieve clinical pregnancy with true
acupuncture.
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Figure 5. Forest plot of comparison: 1 True acupuncture versus sham acupuncture, outcome: 1.4 Clinical
pregnancy rate.
Restored regular menstrual period
Lim 2014 reported difference in intermenstrual days pre and post
treatment. Number of intermenstrual days may have improved
in participants receiving true acupuncture compared to sham
acupuncture (MD -312.09 days, 95% CI -344.59 to -279.59; 1
RCT, 141 women; low-quality evidence; Analysis 1.5; Lim 2014).
Miscarriage rate
For true acupuncture versus sham acupuncture, we could not ex-
clude clinically relevant differences in miscarriage rate (RR 1.10,
95% CI 0.77 to 1.56; 1 RCT, 926 women; low-quality evidence;
Analysis 1.6; Wu 2017). This means, low-quality evidence sug-
gested that if 11% of women had a miscarriage with sham acupunc-
ture, between 9% and 18% would have a miscarriage with true
acupuncture.
Adverse events
All three studies reported adverse events. True acupuncture prob-
ably worsened adverse events compared to sham acupuncture (RR
1.16, 95% CI 1.02 to 1.31; I2 = 0%; 3 RCTs, 1230 women;
moderate-quality evidence; Analysis 1.7; Figure 6; Lim 2014;
Pastore 2011; Wu 2017). This means, moderate-quality evidence
suggested that if 40% of women had adverse events with sham
acupuncture, between 41% and 52% of women had adverse events
with true acupuncture.
Figure 6. Forest plot of comparison: 1 True acupuncture versus sham acupuncture, outcome: 1.7 Adverse
events.
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Pastore 2011 reported one adverse event (back muscle spasm)
and Lim 2014 found no adverse events (based on unpublished
data). Wu 2017 reported 99 adverse events in 500 women who
received true acupuncture compared to 55 adverse events in 500
women who received sham acupuncture before conception. The
most common adverse events in the true acupuncture group were
bruising and diarrhoea. One participant with liver dysfunction
and one participant with fracture of coccyx were reported in the
true acupuncture plus Clomiphene group. Among participants
who conceived there were 174 adverse events in 159 women in
the true acupuncture group compared to 182 adverse events in
161 women in the sham acupuncture group. The most common
adverse events in the true acupuncture group were oedema and
threatened abortion. In terms of serious adverse effects, there were
two participants with ectopic pregnancy, two participants with
late abortion, seven participants with preterm labour, eight partic-
ipants with gestational diabetes, one participant with severe pre-
eclampsia, three participants with placenta previa and one partic-
ipant with preterm labour.
2 Low-frequency electroacupuncture versus lifestyle
intervention (physical exercise) or no intervention
Jedel 2011 compared low-frequency electroacupuncture to phys-
ical exercise or no intervention.
Primary outcomes
Live birth rate
No studies reported live birth rate.
Multiple pregnancy rate
No studies reported multiple pregnancy rate.
Ovulation rate
No studies reported ovulation rate.
Secondary outcomes
Clinical pregnancy rate
No studies reported pregnancy rate.
Restored regular menstrual period
Jedel 2011 reported difference in menstrual frequency before
and after treatment. In this study, one menstruation per month
was defined as a menstrual frequency of 1.0. We were uncertain
whether low-frequency electroacupuncture improved menstrua-
tion frequency at 32 weeks in women who received low-frequency
electroacupuncture compared to physical exercise (MD 0.22, 95%
CI -0.01 to 0.45; 1 RCT, 40 women; very low-quality evidence).
We were uncertain whether low-frequency electroacupuncture im-
proved menstrual frequency at 32 weeks compared to no interven-
tion (MD 0.37, 95% CI 0.21 to 0.53; 1 RCT, 31 women; very
low-quality evidence; Analysis 2.1).
Miscarriage rate
No studies reported miscarriage rate.
Adverse events
There were three cases of skin erythema, one case of dizziness and
one case of nausea following low-frequency electroacupuncture.
No other short-term or long-term adverse events were reported in
either physical exercise group or no intervention group (Analysis
2.2).
3 True acupuncture versus lifestyle intervention
(relaxation)
Johansson 2013 compared true acupuncture on a twice weekly
regimen to relaxation sessions at the same settings.
Primary outcomes
Live birth rate
No studies reported live birth rate.
Multiple pregnancy rate
No studies reported multiple pregnancy rate.
Ovulation rate
We were uncertain whether true acupuncture improved ovulation
frequency (defined as ovulations per month) compared to relax-
ation (MD 0.35, 95% CI 0.14 to 0.56; 1 RCT, 28 women; very
low-quality evidence; Analysis 3.1).
Secondary outcomes
Clinical pregnancy rate
No studies reported pregnancy rate. One participant in Johansson
2013 became pregnant before baseline assessment and she was not
included in the ITT analysis.
Restored regular menstrual period
No studies reported restored regular menstrual period.
Miscarriage rate
No studies reported miscarriage rate.
Adverse events
No studies reported adverse events.
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4 True acupuncture versus conventional treatment
(clomiphene)




No studies reported live birth rate.
Multiple pregnancy rate
No studies reported multiple pregnancy rate.
Ovulation rate
No studies reported ovulation rate. Du 2011 reported number
of ovulations during treatment. However, we could not calculate
ovulation rate because the number of women who had no ovula-




No studies reported pregnancy rate.
Restored regular menstrual period
We were uncertain whether true acupuncture improved restored
regular menstrual period compared to clomiphene. Du 2011 re-
ported restoration of menstruation at the end of treatment and
one month after the end of treatment. During treatment, 14/30
women from the acupuncture group reported restored menstrua-
tion, defined as three normal menstruations during three months.
Eleven out of 30 women in the clomiphene group reported re-
stored menstruation at the end of treatment (RR 1.64, 95%
CI 0.94 to 2.85; 1 RCT, 60 women; very low-quality evidence;
Analysis 4.1). This means, very low-quality evidence suggested that
if 37% of women achieved restored menstruation at end of treat-
ment with clomiphene, between 34% and 100% would achieve
restored menstruation at end of treatment with true acupuncture.
At one month after treatment, 24/30 women in the acupuncture
group reported normal menstruation while 16/30 women in the
clomiphene group reported normal menstruation (RR 1.50, 95%
CI 1.03 to 2.19; 1 RCT, 60 women; very low-quality evidence;
Analysis 4.1). This means, very low-quality evidence suggested
that if 53% of women achieved normal menstruation at one af-
ter treatment with clomiphene, between 55% and 100% would
achieve normal menstruation at one month with true acupunc-
ture.
Miscarriage rate
No studies reported miscarriage rate.
Adverse events
Du 2011 reported three cases of mild subcutaneous haematoma in
the acupuncture group. There were two cases of minor gastroin-
testinal adverse effects in the clomiphene group (Analysis 4.2).
5 True acupuncture versus conventional treatment
(Diane-35)
Cao 2017 and Jin 2016 compared acupuncture to Diane-35. The




For women seeking symptom control, no fertility outcomes were
measured.
Multiple pregnancy rate
For women seeking symptom control, no fertility outcomes were
measured.
Ovulation rate
We were uncertain whether true acupuncture improved ovula-
tion rate compared to Diane-35 (RR 1.45, 95% CI 0.87 to 2.42;
1 RCT, 58 women; very low-quality evidence; Analysis 5.1; Jin
2016). This means, very low-quality evidence suggested that if
39% of women achieved ovulation with Diane-35, between 34%
and 95% would achieve ovulation with true acupuncture. Ovula-
tion was measured by ultrasound three months after treatment.
Secondary outcomes
Clinical pregnancy rate
For women seeking symptom control, no fertility outcomes were
measured. However, Jin 2016 observed that two participants in
the acupuncture group reported pregnancy and were subsequently
withdrawn from the study.
Restored regular menstrual period
We were uncertain whether true acupuncture restored regular
menstrual period compared to Diane-35.
Quantitative meta-analysis of data was not possible due to hetero-
geneity in, and reporting of, outcomes.
We were uncertain whether true acupuncture improved menstrual
restoration rate three months after end of treatment compared to
Diane-35 (RR 1.27, 95% CI 0.92 to 1.77; 1 RCT, 68 women;
very low-quality evidence; Jin 2016). This means, very low-qual-
ity evidence suggested that if 61% of women achieved menstrual
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restoration three months after end of treatment with Diane-35, be-
tween 56% and 107% would achieve menstrual restoration three
months after the end of treatment with true acupuncture.
We were uncertain whether true acupuncture improved menstrual
frequency within three months before and after treatment com-
pared to Diane-35 (MD -0.77, 95% CI -1.20 to -0.34; one RCT,
52 women; very low-quality evidence; Cao 2017).
We were uncertain whether true acupuncture improved menstrual
duration within three months before and after treatment compared
to Diane-35 (MD -0.71, 95% CI -3.48 to 2.06; one RCT, 52
women; very low-quality evidence; Cao 2017).
Miscarriage rate
No studies reported miscarriage rate.
Adverse events
There were one (Jin 2016) and two (Cao 2017) cases of mild
subcutaneous haematoma in the true acupuncture group. There
were two cases of nausea (Cao 2017), one case of headache (Cao
2017), one case of gastrointestinal upset (Jin 2016), and one case
of weight gain (Jin 2016) following Diane-35 (Analysis 5.2).
Other analyses
There were too few studies to conduct any of our planned subgroup
and sensitivity analyses, or to construct a funnel plot to assess risk
of publication bias.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Low- frequency electroacupuncture compared to physical exercise or no intervention for polycystic ovarian syndrome
Patient or population: polycyst ic ovarian syndrome
Setting: outpat ient
Intervention: low-f requency electroacupuncture
Comparison: physical exercise or no intervent ion




Quality of the evidence
(GRADE)
Risk with physical exercise
or no intervention
Risk with low- frequency
electroacupuncture
Live birth rate No studies reported on live birth rate
Multiple pregnancy rate No studies reported on mult iple pregnancy rate
Ovulation rate No studies reported on ovulat ion rate
Restored regular menstrual
period - low-f requency elec-
troacupuncture vs physical
exercise
The mean restored men-
struat ion f requency in the
physical exercise group was
0.11 (SD 0.36)
The mean restored men-
struat ion f requency in










period - low-f requency elec-
troacupuncture vs no inter-
vent ion
The mean restored men-
struat ion f requency in the
no intervent ion group was -
0.04 (SD 0.07)
The mean restored men-
struat ion f requency in








































































































0 per 1000 0 per 1000
(0 to 0)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; MD: mean dif ference; RCT: randomised controlled trial; RR: risk rat io; SD: standard deviat ion.
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded two levels for high risk of performance bias and detect ion bias.
bDowngraded two levels for imprecision - single study with small sample size.
cFive cases of adverse events were recorded in the low-f requency electroacupuncture group and no adverse events were


























































































True acupuncture compared to relaxation for polycystic ovarian syndrome
Patient or population: polycyst ic ovarian syndrome
Setting: outpat ient
Intervention: t rue acupuncture
Comparison: relaxat ion




Quality of the evidence
(GRADE)
Risk with relaxation Risk with true acupuncture
Live birth rate No studies reported on live birth rate
Multiple pregnancy rate No studies reported on mult iple pregnancy rate
Ovulation rate The mean ovulat ion rate
was 0
MD 0.35 higher





Adverse events No studies reported on adverse events
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; MD: mean dif ference; RCT: randomised controlled trial.
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for high risk of performance bias.


























































































True acupuncture compared to clomiphene for polycystic ovarian syndrome
Patient or population: polycyst ic ovarian syndrome
Setting: outpat ient
Intervention: t rue acupuncture
Comparison: clomiphene




Quality of the evidence
(GRADE)
Risk with clomiphene Risk with true acupuncture
Live birth rate No studies reported on live birth rate
Multiple pregnancy rate No studies reported on mult iple pregnancy rate
Ovulation rate No studies reported on ovulat ion rate
Restored regular menstrual
period - restored menstrua-
t ion at the end of treatment






367 per 1000 601 per 1000
(345 to 1000)
Restored regular menstrual
period - restored menstru-
at ion 1 month af ter end of
treatment






533 per 1000 800 per 1000
(549 to 1000)






33 per 1000 44 per 1000
(10 to 194)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).


























































































GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded two levels for high risk of performance bias, detect ion bias, report ing bias and other bias.
bDowngraded two levels for imprecision - single study with small sample size and conf idence intervals compatible with
benef it in either arm or no ef fect.



























































































True acupuncture compared to Diane-35 for polycystic ovarian syndrome
Patient or population: polycyst ic ovarian syndrome
Setting: outpat ient
Intervention: t rue acupuncture
Comparison: Diane-35




Quality of the evidence
(GRADE)
Risk with Diane-35 Risk with true acupuncture
Live birth rate For women seeking symptom control, no fert ility outcomes were measured
Multiple pregnancy rate For women seeking symptom control, no fert ility outcomes were measured






394 per 1000 571 per 1000
(343 to 953)






29 per 1000 20 per 1000
(7 to 57)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; RCT: randomised controlled trial; RR: risk rat io.
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.


























































































aDowngraded two levels for high risk of performance bias, detect ion bias, attrit ion bias and other bias.
bDowngraded two levels for imprecision - single study with small sample size and conf idence intervals compatible with
benef it in either arm or no ef fect.
cDowngraded two levels for high risk of performance bias, detect ion bias and attrit ion bias in two studies; addit ional high risk
of other bias in one study.




























































































D I S C U S S I O N
Summary of main results
This review assessed the effectiveness and safety of acupunc-
ture treatment for oligo/anovulatory women with PCOS. We
found five studies that compared true acupuncture versus sham
acupuncture, one study compared low-frequency electroacupunc-
ture and physical exercise and no intervention, one study com-
pared acupuncture with clomiphene and two studies compared
acupuncture and Diane-35. A total of 1546 women with PCOS
were included in this review.
For true acupuncture versus sham acupuncture, we could not ex-
clude clinically relevant differences in live birth, multiple preg-
nancy rate, ovulation rate, clinical pregnancy rate and miscarriage
rate. Number of intermenstrual days may have improved in partic-
ipants receiving true acupuncture compared to sham acupuncture.
True acupuncture probably worsened adverse events compared to
sham acupuncture. Quality of evidence ranged from moderate to
very low quality.
No studies reported data on live birth rate and multiple pregnancy
rate for the other comparisons: physical exercise or no intervention,
relaxation and clomiphene. Studies including Diane-35 did not
measure fertility outcomes.
We were uncertain whether acupuncture improved ovulation rate
(measured by ultrasound three months post treatment) compared
to relaxation or Diane-35. The other comparisons did not report
ovulation rate.
Adverse events were recorded in the acupuncture group for the
comparisons physical exercise or no intervention, clomiphene and
Diane-35. These included dizziness, nausea and subcutaneous
haematoma. Evidence was very low quality with very wide CIs and
very low event rates.
Overall completeness and applicability of
evidence
The included studies poorly addressed the primary outcomes of
this review, with only one study reporting the primary outcomes
live birth rate and multiple pregnancy rate. Five of eight stud-
ies addressed the primary outcome ovulation rate; however, there
was significant heterogeneity in reporting and measurement of
ovulation rate. Moreover, there were insufficient data on adverse
events for comparisons other than true acupuncture versus sham
acupuncture, to determine the overall safety of acupuncture as a
treatment for oligo/anovulation in women with PCOS.
Quality of the evidence
We included only eight RCTs in the present review and most had
small sample sizes. Seven of the studies were at high risk of bias in
at least one domain (Cao 2017; Du 2011; Jedel 2011; Jin 2016;
Johansson 2013; Pastore 2011; Wu 2017). The evidence ranged
from very low quality to moderate quality, the main limitations
being failure to report important clinical outcomes, and very seri-
ous imprecision.
Potential biases in the review process
We did not search any non-English or non-Chinese databases,
hence studies published in languages other than English or Chinese
may not have been identified in the review process. However, there
was no exclusion of study that was due to language. There may
also have been unpublished data that our searches did not find. In
addition, one included study was published by an author (DL) of
this review (Lim 2014).
In order to minimise any potential risk of bias during the review
process, two review authors (RN, GZ) independently extracted
data using a piloted data extraction form. Specifically, the author
(DL) of one of the primary studies (Lim 2014) was excluded to
extract data from their own study. All studies were then assessed
independently and any dispute was resolved by a fifth independent
author (HC).
Agreements and disagreements with other
studies or reviews
Several systematic reviews have examined acupuncture for PCOS.
Jo 2017 conducted a systematic review and meta-analysis on
acupuncture for PCOS which included 27 RCTs comparing
acupuncture with sham acupuncture, medication, no treatment or
acupuncture combined with medication. The review found similar
results to this review, reporting very limited evidence for acupunc-
ture in improving ovulation, menstruation rates and hormonal
changes. Qu 2016 included nine RCTs in a systematic review and
meta-analysis which included studies comparing acupuncture with
sham acupuncture or acupuncture in addition to other treatment.
Unlike this study, the authors found significant improvement in
recovery of menstrual cycles and lower BMI and LH levels. How-
ever, there was no evidence in improvement of other hormonal
parameters. Similar to this study, Qu 2016 found that studies had
unclear or high risks of bias in multiple domains and limited qual-
ity.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
For true acupuncture versus sham acupuncture, we cannot exclude
clinically relevant differences in live birth rate, multiple pregnancy
rate, ovulation rate, clinical pregnancy rate or miscarriage. Number
of intermenstrual days may improve in participants receiving true
acupuncture compared to sham acupuncture. True acupuncture
probably worsens adverse events compared to sham acupuncture.
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No studies reported data on live birth rate and multiple pregnancy
rate for the other comparisons: physical exercise or no intervention,
relaxation and clomiphene. Studies including Diane-35 did not
measure fertility outcomes.
We are uncertain whether acupuncture improves ovulation rate
(measured by ultrasound three months post treatment) compared
to relaxation or Diane-35. The other comparisons did not report
on this outcome.
There were adverse events in the acupuncture group for the com-
parisons physical exercise or no intervention, clomiphene and
Diane-35. These included dizziness, nausea and subcutaneous
haematoma. Evidence was very low quality with very wide confi-
dence intervals and very low event rates.
There are only a limited number of randomised controlled trials
(RCT) in this area, limiting our ability to determine effectiveness
of acupuncture for polycystic ovarian syndrome (PCOS).
Implications for research
Given the lack of evidence for acupuncture for PCOS, further
large-scale, properly designed RCTs are needed to assess the use of
acupuncture in the management of PCOS. Women with PCOS
meeting standard diagnostic criteria (e.g. Rotterdam consensus)
seeking fertility or symptom control should be recruited and an
acupuncture regimen involving a set of standard acupuncture
points and mode of stimulation should be considered. Controls
should also receive a standard regimen of sham acupuncture in or-
der to minimise the potential therapeutic effects of sham acupunc-
ture. Consistent, standard outcome measures including live birth
rate should be reported.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cao 2017
Methods Method: randomised controlled trial
Blinding: nil
Intervention: acupuncture
Control: Diane-35 (ethinylestradiol and cyproterone acetate tablets)
Time: treatments for 12 continuous weeks.
Participants Country: China
Number of participants: 56
Inclusion criteria
• Aged 18-45 years
• Fulfilled PCOS diagnostic criteria set by Rotterdam consensus
• No hormone or other treatment in the last 3 months that affecting reproductive
hormones
• No severe illness
• Willing to sign the consent form
Exclusion criteria
• Blood pressure > 160/100 mmHg
• Diabetes, neurological conditions, retina disorders, liver and kidney disorders,
mental disorders, and malignant tumours
• Under hormone replacement therapy within the last 3 months
• Smoking > 15 cigarettes/day
• Have pacemaker, be allergic to metal or have needle phobia
Interventions Acupuncture
• 30 minutes 2 times/week for 12 weeks
Following were treated bilaterally, Fuke, Huanchao, Tianhuang (Yinlingquan, SP 9),
Renhuang (Sanyinjiao, SP 6), Guanyuan (CV 4), Zigong (EX-CA 1)
Diane-35
• Once a day for 21 days with 7 days treatment-free interval between 2 sessions.
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Cao 2017 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants randomised using random
number method
Allocation concealment (selection bias) Unclear risk No concealment described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding described (difficult to blind
when using different method)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding described
Incomplete outcome data (attrition bias)
All outcomes
High risk 4/56 women dropped out during the inter-
vention phase. The difference between age,
BMI or clinical feature of the dropouts and
the remainder of the cohort was not per-
formed. There was no ITT analysis
Selective reporting (reporting bias) Low risk All listed outcomes reported
Other bias Unclear risk No other potential bias identified
Du 2011




Time: treatment for 3 continuous months or pregnancy. Follow-up 1 month
Participants Country: China
Number of participants: 60
Inclusion criteria
• Aged 20-35 years
• Oligomenorrhoea, infertility or amenorrhoea
• Fulfilled PCOS diagnostic criteria set by Rotterdam consensus and relevant
traditional diagnosis
Exclusion criteria
• Severe comorbid illness including malignancy
• Adrenal disease
• Organ failure
• Severe liver, kidney, cardiovascular or cerebrovascular disease
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Du 2011 (Continued)
Interventions Acupuncture
• 3 × 30-day cycles of acupuncture regimen from 5th day of menstruation or
progesterone-induced withdrawal bleeding. Following points were treated bilaterally:
Zhongwan Ren 12, Xiawan Ren 10, Qihai Ren 6, Guanyuan Ren 4, Zhongji 4 (RN 3)
, Dahe 12 (Ki 12), Shuidao (ST 28), lower rheumatism points, Qixue (Ki 13)
Clomiphene
• 50 mg/day for 5 days from 5th day of menstruation or progesterone-induced
bleeding in women with amenorrhoea. Regimen repeated for 3 months





• Ultrasound performed to evaluate ovulation at day 14 of menstrual cycle
Notes Study was from an unpublished thesis for Master’s degree at Guangzhou University of
Chinese Medicine
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation with PEMS
3.1 software was used to allocate partici-
pants at 1:1 ratio into 2 groups
Allocation concealment (selection bias) Low risk Computer-generated sequences were sealed
in numbered opaque envelops. Participants
were allocated sequentially to envelops
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants and personnel was
not described. However, blinding of par-
ticipants or practitioner was unlikely given
nature of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk No withdrawal or exclusion after enrol-
ment
Selective reporting (reporting bias) High risk Number of women with no ovulation dur-
ing treatment period not reported
Other bias High risk Reported as a part of thesis, instead of pub-
lished in a peer-reviewed journal
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Jedel 2011
Methods Method: randomised controlled clinical trial
Blinding: nil
Intervention: low-frequency electroacupuncture, physical exercise
Control: no active intervention
Time: 12-week observation period and baseline assessment, 16-week intervention, 16-
week follow-up
Participants Country: Sweden
Number of participants: low-frequency electroacupuncture: 33; physical exercise: 34; no
active intervention: 17
Inclusion criteria
• Ultrasound-verified polycystic ovaries with 12 follicles 2-9 mm or an ovarian
volume of 10 mL in 1 or both ovaries (or both) together with oligo/amenorrhoea or
clinical signs of hyperandrogenism (hirsutism or acne), or a combination of these
Exclusion criteria
• Aged ≥ 38 years
• Any pharmacological treatment within 12 weeks or breastfeeding within 24 weeks
of entering the study
• Cardiovascular disease, diabetes mellitus, and endocrine or neoplastic causes of
hyperandrogenaemia, including androgen-secreting tumours, Cushing’s syndrome,
congenital adrenal hyperplasia and hyperprolactinaemia
Interventions 3 groups
Low-frequency electroacupuncture
• Twice weekly for 2 weeks, once weekly for 6 weeks, and once every other week for
8 weeks, for a total of 14 treatments over 16 weeks
• Electroacupuncture points (low-frequency electroacupuncture 2 Hz): CV 3, CV
6, ST 29, SP 6, SP 9 and LI 4, or PC 6 bilaterally
Physical exercise
• Brisk walking, cycling or any other aerobic exercise at a self-selected pace
described as “faster than normal walking at a pace that could be sustained for at least
30 min at least 3 days per week.”
• Physical exercise was self-monitored with a heart rate monitor to ensure a heart
rate ≥ 120 beats/minute.
No active intervention
• Telephone information only
Outcomes Primary outcomes
• Changes in serum T between low-frequency electroacupuncture and physical
exercise at week 16
Secondary outcomes
• Changes in serum T between low-frequency electroacupuncture and physical
exercise at week 32
• Changes in menstrual frequency, acne and hirsutism, free T, 5α-
dihydrotestosterone, oestrone, oestrone sulphate, oestradiol, dehydroepiandrosterone,
dehydroepiandrosterone sulphate, androstenedione, 5-androstene-3β, 17β-diol,
androsterone glucuronide, 17β-diol-3glucuronide, 17β-diol-17-glucuronide, sex
hormone-binding globulin, LH, FSH, LH:FSH ratio, BMI and maximum rate of
oxygen consumption at weeks 16 and 32 between low-frequency electroacupuncture
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Jedel 2011 (Continued)
and physical exercise
• Changes in primary and secondary outcome measures at weeks 16 and 32
between low-frequency electroacupuncture and no active intervention and between




Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants stratified by age and BMI
and randomised using computer-generated
randomisation
Allocation concealment (selection bias) Low risk Concealed until interventions assigned.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding described.
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding described.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Numbers and reasons for dropout in all
phases were described. No comparison of
baseline characteristics of dropouts and
those remaining in trial was reported
ITT analysis performed.
Selective reporting (reporting bias) Low risk All listed outcomes reported.
Other bias Unclear risk No other potential bias identified.
Jin 2016
Methods Method: randomised controlled trial
Blinding: nil
Intervention: acupuncture
Control: Diane-35 (ethinylestradiol and cyproterone acetate tablets)
Time: treatments for 3 months
Participants Country: China
Number of participants: 72
Inclusion criteria
• Fulfilled PCOS diagnostic criteria set by Rotterdam consensus (2 out of 3 criteria)
• Aged 18-35 years
40Acupuncture for polycystic ovarian syndrome (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Jin 2016 (Continued)
• Main complaint of oligo-amenorrhoea or infertility
• Menstrual cycle 35 days - 6 months
• Menstrual bleeding ≤ 8 days
• Liver stagnation score ≥ 3 (inhouse method)
• No hormone or other treatment in the last 3 months that affected reproductive
hormones
• No severe illness
• Willing to sign the consent form
Exclusion criteria
• Prolonged bleeding duration
• Acute gynaecological infection, endometriosis, premature ovarian failure, ovarian
cyst
• Hyperinsulinaemia, fasting insulin level ≥ 85 pmol/L
• Hyperprolactinaemia, prolactin ≥ 25 ng/mL
• Primary liver, kidney, and blood disorders, mental disorders
• Under other treatment
• Unable to follow the treatment instructions
Interventions Acupuncture
• 30 minutes 3 times/week for 3 months, in total 40 treatments
• Danzhong (CV 17), zhongwan (CV 12), Guanyuan (CV 4)
• Following were treated bilaterally: Qimen (LR 14), Ganshu (BL 18), Tianshu (ST
25), sanyinjiao (SP 6), zusanli (DT 36), taichong (LV 3), Zigong (EX-CA 1)
• After deqi, Zhongwan, Guanyuang, Zigong and Tianshu were connected with
electric needles.
Diane-35
• From the 5th day of bleeding, once/day for 21 days with 7 days’ treatment-free
interval between 2 sessions. Regimen was repeated for 3 menstrual cycles.
Outcomes • Safety
• BMI













Bias Authors’ judgement Support for judgement
41Acupuncture for polycystic ovarian syndrome (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Jin 2016 (Continued)
Random sequence generation (selection
bias)
Low risk Participants randomised using computer
method.
Allocation concealment (selection bias) Unclear risk No concealment described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding described (difficult to blind
when using different method)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding described.
Incomplete outcome data (attrition bias)
All outcomes
High risk 4/72 dropped out during the intervention
phase. The difference between age, BMI
or clinical feature of the dropouts and the
remainder of the cohort was not performed.
No ITT analysis
Selective reporting (reporting bias) Low risk All listed outcomes reported.
Other bias High risk Reported as a part of thesis, instead of pub-
lished in a peer-reviewed journal
Johansson 2013
Methods Method: randomised controlled trial
Blinding: single, investigators blinded until statistical analysis
Intervention: acupuncture
Control: relaxation
Time: 10-13 weeks’ intervention. Measurements were taken within 1 week of interven-
tions
Participants Country: Sweden
Number of participants: acupuncture: 16; relaxation: 16
Inclusion criteria
• PCOS diagnosed according to the Rotterdam consensus
Exclusion criteria
• Aged < 18 or > 38 years
• BMI > 30
• Any pharmacological therapy in previous 3 months
• Breastfeeding in prior 24 weeks
• Cardiovascular disease
• Diabetes mellitus
• Other endocrine diseases
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Johansson 2013 (Continued)
Interventions Acupuncture
• Twice weekly acupuncture session with alternating 11 (CV 3, CV 6, ST 29, SP 6,
SP 9, LI 4, GV 20) or 13 (CV 3, CV 6, ST 25, ST 29, SP 6, LR 3, PC 6, GV 20) point
protocols
Attention control (relaxation)
• Visit to the same therapist for the same amount of time, consisting of relaxation
and resting
Outcomes Primary outcomes
• Ovulation frequency, confirmed by bleeding and progesterone measurement
• LH secretion pattern from baseline to the end of treatment
Secondary outcomes
• Measurements of fasting glucose, insulin level, anti-Mullerian hormone level,
inhibin B level, lipid profile, sex hormone binding globulin level, ovarian volume,
endometrial thickness, antral follicle by ultrasound, body fat percentage, hirsutism
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants or therapists was
not possible because of natures of interven-
tion and control in this study
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Biological outcomes were measured at an
independent laboratory. It was unclear
what was meant by “investigators were
blinded until statistical analyses.” There
was potential risk from blinding of out-
come assessment if blinding was stopped
prior to statistical analysis
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts were adequately described.
Selective reporting (reporting bias) Unclear risk All predetermined outcomes were reported.
However, there was no mention of adverse
events
Other bias Unclear risk No other potential bias identified.
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Lim 2014





Participants Country: Australia and China
Number of participants: acupuncture: 98: sham acupuncture: 48
Inclusion criteria
• Rotterdam consensus diagnostic criteria
• Kidney yang deficiency syndrome as per Chinese medicine diagnosis
Exclusion criteria
• Lack of consent to agree to participate in the study determined through the
informed consent forms given to qualifying women
• Aged < 18 years
• Abnormal full blood count, renal or liver function tests
Interventions True acupuncture
• Ren 3, M-CA 18, SP 6, Ren 4, ST 36, ST 40, LV 3, ST 29 and SP 10
Sham body acupuncture
• 10 mm outside the classical point and outside of the meridian using superficial
needling methods
Intervention frequency: weekly for 3 months
Outcomes Primary outcome
• Return of menstruation from amenorrhoea
Secondary outcomes
• Changes in serum hormone profiles (LH and FSH concentration, LH:FSH ratio,
progesterone concentration, oestrogen concentration, androgenic hormone
concentration)
Notes Live birth was not measured. Clarification from author was sought regarding adverse
events. There were no adverse events noted in the study and hence was not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation achieved by computer-
generated program.
Allocation concealment (selection bias) Low risk Presealed identical envelopes used.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Trial described as single blinded, only par-
ticipants were blinded
Blinding of outcome assessment (detection
bias)
Low risk Outcome assessment was done by statisti-
cians who were independent of the study
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Lim 2014 (Continued)
All outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk Number and reason for dropout between
enrolment and allocation were described.
No participants dropped out or lost to fol-
low-up during intervention
Selective reporting (reporting bias) Unclear risk All listed outcomes were reported; however,
adverse effects were not reported
Other bias Unclear risk No other potential bias identified.
Pastore 2011






Number of participants: acupuncture: 46; sham acupuncture: 50
Inclusion criteria
• Women with PCOS confirmed by presence of oligomenorrhoea and
hyperandrogenism
• Aged 18-43 years
• ≥ 1 menses in the last 6 months but no more than 8 menses in the most recent 12
months without hormonal intervention
• Agreement to not take hormonal contraceptives, metformin or fertility
medication for the 5 months of study participation
Exclusion criteria
• Diagnosed with Cushing’s syndrome, uncontrolled thyroid disease,
hyperprolactinaemia, congenital adrenal hyperplasia or diabetes mellitus
• Use of metformin or hormonal contraceptives in the 60 days before enrolment
• Use of any other hormonal drug in the 30 days before entry into study, including
fertility medications, and non-prescription hormonal supplements or herbs (i.e. black
cohosh, clover, soy, dong quai/Chinese angelica root, fructus rubi, white peony root)
• Currently pregnant or breastfeeding during the prior 30 days
• Any acupuncture treatment for ovulatory disorders in the prior 30 days
• Weight > 250 lb (113 kg) because these women were reported to be the most
resistant to medical intervention at the time of our study design development
• Currently taking anticoagulation medication other than low-dose (≤ 81 mg)
aspirin
• Immune deficiency
• History of any bleeding disorder
Interventions Time: 12 acupuncture/sham session: twice weekly for the first 4 weeks followed by once
weekly for an additional 4 weeks
True acupuncture
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Pastore 2011 (Continued)
• Electroacupuncture points: BL 23, BL 28, SP 6 and SP 9 bilaterally
• Manual stimulation: PC 6, TE 5 and GV 20
Sham acupuncture




Notes Authors contacted for data regarding live births (primary outcome) but data not available
from authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation achieved by random num-
ber generator program.
Participants stratified by obese (BMI) and
non-obese.
Allocation concealment (selection bias) Low risk Consecutive study identifications were as-
signed to a treatment arm by a graduate
student independent of the study
Quote: “These assignments were placed
in individual sealed, opaque envelopes la-
belled with the study identifications.”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The trial was described as blinded, parties
who were blinded and method of blinding
was described
Quote: “The participants, principal inves-
tigator, clinical research coordinator, and
biostatistician (J.T.P.) were all blind to the
intervention arm.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The trial was described as blinded, parties
who were blinded and method of blinding
was described
Quote: “The participants, principal inves-
tigator, clinical research coordinator, and
biostatistician (J.T.P.) were all blind to the
intervention arm.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Number and reason for dropout during in-
tervention described. Number and reason
for dropout during 3-month follow-up not
given
ITT not performed
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Pastore 2011 (Continued)
Selective reporting (reporting bias) Low risk All listed outcomes reported.
Other bias Unclear risk No other potential bias identified.
Wu 2017
Methods Method: factorial trial
Blinding: acupuncture double blinded to participants and study investigators, known
to acupuncturists and data manager at each site; clomiphene and placebo assignments
double blinded to participant and study investigators, known to data manager at each
site
Intervention: acupuncture, clomiphene
Control: control acupuncture and placebo drug
Participants Country: China
Number of participants: active acupuncture + clomiphene: 250; control acupuncture +
clomiphene: 250; active acupuncture + placebo: 250; control acupuncture + placebo:
250
Inclusion criteria
• Modified Rotterdam criteria: oligomenorrhoea or amenorrhoea, together with
clinical or biochemical hyperandrogenism (modified Ferriman-Gallwey hirsutism score
≥ 5 in Chinese) or polycystic ovaries, or both
Exclusion criteria
• Other endocrine disorders resembling PCOS, including hyperprolactinaemia,
uncorrected thyroid disease, Type I or Type II diabetes, and Cushing’s syndrome
• Use of hormonal or other medication including Chinese herbal prescriptions in
the past 3 months
• Pregnancy with the past 6 weeks
• Within 6 weeks postabortion or postpartum
• Breastfeeding within the last 6 months
• Not willing to give written consent to the study
Interventions Participants randomised to 4 arms
• Active acupuncture + clomiphene
• Control acupuncture + clomiphene
• Active acupuncture + placebo
• Control acupuncture + placebo
Active acupuncture
• Acupuncture treatment for 30 minutes twice weekly, maximum of 32
acupuncture treatments
• 2 sets of acupuncture points alternated every second treatment
• First set: CV 3, CV 6, ST 29, SP 6, SP 9, LI 4 bilaterally; GV 20
◦ All points stimulated manually first
◦ CV 3, CV 6, ST 29, SP 6 and SP 9 then stimulated with low-frequency
electroacupuncture
• Second set
◦ ST 25, ST 29, SP 6 and LR 3 bilaterally stimulated with low-frequency
electroacupuncture
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◦ CV 3, CV 6 and GV 20; PC 6 bilaterally with manual stimulation
Control acupuncture
• Acupuncture treatment for 30 minutes twice weekly, maximum of 32
acupuncture treatments
• Needles inserted to a depth of < 5mm, 1 in each shoulder and 1 in each upper
arm at non-acupuncture points
• Electrodes attached and stimulator turned on at an intensity of 0
• No manual stimulation of needles performed
Clomiphene
• Clomiphene citrate 50mg/day (1 tablet) for 5 days from days 3 to 7 of the
menstrual cycle
• Dosage of clomiphene citrate increased by 50 mg (1 tablet) in absence of
ovulation or maintained in the presence of ovulation
• Maximum dosage of clomiphene citrate did not exceed 150 mg/day or 750 mg/
cycle
• Treatment repeated for up to 4 cycles
Placebo
• Placebo tablet in place of clomiphene tablet with same increase in tablet schedule
as clomiphene citrate
Outcomes Primary outcome
















Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation stratified within 21 partic-
ipating sites and defined with a random
block size of 4 or 8. Participants were ran-
domly allocated in a ratio of 1:1:1:1 into 1
of 4 intervention groups by an interactive
online computer program in a central of-
fice
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Allocation concealment (selection bias) Low risk Medication bottles had preprinted barcode
labels and were distributed to sites and as-
signed to the participants as they were en-
rolled
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Active and control acupuncture treatments
single blinded to participant. Treatments
known to acupuncturists and data manager
at each site
Clomiphene and placebo assignments dou-
ble blinded to participants and study inves-
tigators. Known to data manager
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not described in the report.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Numbers and reasons for dropout in all
phases were described
4 participants who conceived after ran-
domisation and before intervention com-
menced. These participants completed the
last visit and were included in the primary
analysis. During the intervention phase, 74
participants dropped out from the study.
15 participants dropped out from the ac-
tive acupuncture + clomiphene arm; 14
participants dropped out from the con-
trol acupuncture + clomiphene arm; 27
participants dropped out from the active
acupuncture + placebo arm and 18 par-
ticipants dropped out from the control
acupuncture + placebo arm. Out of the
14 participants who dropped out from the
control acupuncture + clomiphene arm, 2
were due to intervention adverse effects.
Out of the 27 participants who dropped
out from the active acupuncture + placebo
arm, 3 were due to intervention adverse ef-
fects. There was no ITT analysis
Selective reporting (reporting bias) Low risk All listed outcomes were reported.
Other bias Low risk Conflict of interest disclosed by 1 author
(Legro) who reported serving as consultant
to Bayer, Kindex, Euroscreen, Millendo,
Takeda, Clarus, Sprou and AstraZeneca;
serving as a site investigators and receiving
grants from Ferring and AstraZeneca
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The study was supported by various gov-
ernment and non-government grants
Quote: “The funding agencies had no role
in the design and conduct of the study; col-
lection, management, analysis, and inter-
pretation of the data; preparation, review,
or approval of the manuscript; and decision
to submit the manuscript for publication.”
BMI: body-mass index; FSH: follicle-stimulating hormone; ITT: intention to treat; LH: luteinising hormone; PCOS: polycystic ovarian
syndrome.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cai 2016 Additional acupuncture points were used based on traditional Chinese medicine patterns for both electroacupuncture
and acupoint catgut-embedding therapy groups. The frequency for electroacupuncture was not a set value for each
participant
Chen 2014 Acupuncture combined with another therapy. Embedded short suture as additional intervention in acupuncture
group. There was also a lack of outcome measurement specified in this review
Chen 2015b Acupuncture combined with another therapy. Chinese herbal medicine combined with acupuncture, multiple con-
ventional medicine used in control group
Fang 2016 Lack of outcome measures specified in this review.
Hao 2015 Ineligible comparison intervention. 2 different forms of acupuncture compared
He 2017 Lack of outcome measures specified in this review.
Huang 2016 Ineligible intervention, both acupuncture and western medicine were used in treatment group
Jiang 2014 Acupuncture combined with another therapy. Herbal medicine given to all groups apart from clomiphene-only group
Jiang 2015a Acupuncture combined with another therapy. Herbal medicine given to all groups except for clomiphene-only group
Jiang 2015b Ineligible treatment/comparison either using a combination of Chinese herbal medicine and acupuncture, with or
without conventional medicine
Jin 2014 Lack of outcome measures specified in this review.
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Kuang 2013 Acupuncture combined with another therapy. Effects of clomiphene citrate combined with acupuncture as interven-
tion studied
Li 2010 Lack of outcome measures specified in this review.
Li 2011a Diagnostic criteria used differed significantly from Rotterdam consensus
Li 2011b Acupuncture combined with another therapy. Controlled ovarian hyperstimulation given as cointervention to both
groups
Li 2013 Diagnostic criteria used were different from Rotterdam consensus
Li 2014 Acupuncture combined with another therapy. Controlled ovarian hyperstimulation performed on both acupuncture
and conventional group
Li 2015 Ineligible comparison intervention: conventional medicine was used in both groups
Li 2017 Different points were used for each participant during treatments in 2 types of acupuncture regimen
Liu 2012 Acupuncture combined with another therapy. Oral contraceptives given to both groups
Liu 2017 Diagnostic criteria used differed significantly from Rotterdam consensus. It was unclear which type of conventional
medicine was used in the control group. Lack of outcome measure specified in this review
Peng 2017 Ineligible comparator, Electroacupuncture on real points vs manual acupuncture on sham points
Qu 2012 Women with clinical or biochemical hyperandrogenism excluded from the study
Rashidi 2013 Ineligible comparison intervention. Acupuncture compared to in vitro fertilisation treatment instead of treatment
for polycystic ovarian syndrome
Sun 2010 Acupuncture combined with another therapy. Controlled ovarian hyperstimulation given to both groups
Wang 2013 Acupuncture combined with another therapy.
Yang 2015 Not a randomised study. Additional points were used during different stages of menstrual cycle. Multiple drugs were
used for the control group
Yang 2017 Different additional points were used for each participant during treatment of acupuncture
Yu 2013 Ineligible comparison intervention. Acupuncture compared with electrical acupuncture and herbal medicine. Studies
involving herbal medicine excluded because of coexisting review
Zhang 2013 Acupuncture combined with another therapy.
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Zhou 2016 Different additional points were used for each participant during treatment of acupuncture. Multiple type of con-
ventional medicine may be used for patients. Acupuncture treatment duration may be inconsistent due to ultrasound
evaluation of ovulation
Characteristics of ongoing studies [ordered by study ID]
ChiCTR-IOR-15007358
Trial name or title A randomized controlled trial to evaluate the effectiveness of electroacupuncture for polycystic ovary syndrome
Methods Randomised parallel controlled trial
Participants Inclusion criteria
• Women, aged 20-40 years
• Diagnosed with PCOS
• Signed the inform consent
Exclusion criteria
• Allergic constitution or allergic to various types of medicine
• Hyperandrogenism due to other reasons, including hyperprolactinaemia, thyroid disease, congenital
adrenal hyperplasia, Cushing’s syndrome, etc.
• Pathological endometrial changes, uterine malformation, hysteromyoma, etc. diagnosed by B
ultrasound
• Genital tract malformation, gonadal dysgenesis, fallopian tube block, etc.
• Severe heart, liver or renal dysfunction and haematological, respiratory, cardiovascular, psychiatric or
other metabolic diseases
• Within 6 weeks postabortion
• Use of hormonal or other medication including Chinese herbal prescriptions in the past 3 months
• Participation in other clinical trials at the same time
Interventions Electroacupuncture
Clomiphene citrate
Outcomes Ovulation rate, LH, E2, dominant follicle rate
The time point of ovulation, mean number of dominant follicle, follicular size before ovulation, pregnancy
rate
Starting date 1 January 2015
Contact information Feng Shuwei. Chengdu University of TCM
Notes
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Trial name or title Intervention of acupuncture based on metabonomics on key targets of PCOS dampness syndrome
Methods Randomised parallel controlled trial
Participants Inclusion criteria
• Diagnostic criteria for Chinese and Western medicine in accordance with spleen deficiency and
dampness PCOS
• Aged 20-45 years
• Normal liver and kidney function
• To understand and voluntarily join the trial and voluntarily sign the informed consent form.
Exclusion criteria
• People with adrenal, thyroid, pituitary and other endocrine dysfunction, such as adrenal hyperplasia,
adrenal insufficiency, hyperthyroidism, hypothyroidism, pituitary tumour, diabetes, etc.
• People with severe chronic wasting diseases such as heart, liver and kidney
• Nerve and mental diseases; haematological problems; acute genitourinary system inflammation
• People with reproductive system tumours and genital organic diseases
• Taking contraceptives or other hormone-containing drugs within 3 months
• Physiological menstruation and amenorrhoea
• People whose compliance was crossed.
Interventions Acupuncture
Western medicine
Acupuncture + western medicine
Outcomes Biomarkers
Starting date 1 May 2018
Contact information Xiaoxia Li, Shandong University of Traditional Chinese Medicine
Notes
ChiCTR1800017304
Trial name or title A multicenter, randomized, controlled trial for comparing personalized acupuncture versus standardized
acupuncture, versus letrozole, placebo in the treatment of anovulatory women with polycystic ovary syndrome
Methods Randomised, parallel controlled trial
Participants Inclusion criteria
• Women aged 20-40 years
• Chronic oligomenorrhoea or amenorrhoea. Oligomenorrhoea defined as an intermenstrual interval >
35 days or < 8 menstrual bleedings in the past year. Amenorrhea defined as an intermenstrual interval > 90
days
• Hyperandrogenism (either hirsutism or hyperandrogenaemia) or polycystic ovaries on ultrasound.
Hirsutism determined by a modified Ferriman-Gallwey Score at screening examination, and biochemical
hyperandrogenism defined as total testosterone > 2.6 nmol/L and free testosterone 6.0 pg/mL. Polycystic
ovaries present when there were 12 antral follicles (2 - 9 mm) or ovarian volume > 10 mL on transvaginal
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scanning
• ≥ 1 patent tube shown by hysterosalpingogram or diagnostic laparoscopy within 3 years if the
participant did not have a history of abortion or pelvic operation. If the patient had a history of pregnancy
and no history of pelvic operation within the past 5 years, she was not required to undergo a tubal patency
test
• Sperm concentration ≥ 15 × 106/mL and total motility ≥ 40% or total motile sperm count ≥ 10
million in the semen analysis of the husband. Agree to have regular intercourse, i.e. 2-3 times per week
during the study period.
Exclusion criteria
• Exclusion of other endocrine disorders
◦ Hyperprolactinaemia (defined as 2 prolactin levels of 25 ng/mL ≥ 1 week apart)
◦ FSH levels > 15 mIU/mL
◦ Normal level within the last year was adequate for entry
◦ Uncorrected thyroid disease (defined as TSH < 0.2 mIU/mL or > 5.5 mIU/mL). A normal level
within the last year was adequate for entry
◦ Type I or Type II diabetes who were poorly controlled (defined as HbA1c level > 7.0%), or
receiving antidiabetic medications such as metformin, insulin, thiazolidinediones, acarbose or
sulphonylureas
◦ Suspected Cushing’s syndrome
• Use of hormonal or other medication including Chinese herbal prescriptions in the past 3 months
• Pregnancy within the past 6 weeks
• Within 6 weeks postabortion or postpartum
• Breastfeeding within the last 6 months
• Not willing to give written consent to the study
• Additional exclusion criteria as follows
◦ Using oral contraceptives, depot progestins or hormonal implants (including Implanon). A 2-
month washout period was required prior to screening for people on these agents. Longer washouts may
have been necessary for certain depot contraceptive forms or implants, especially where the implants are still
in place. A 1-month washout will be required for people on oral cyclic progestins
◦ Liver disease defined as AST or ALT > 2 times normal or total bilirubin > 2.5 mg/dL. People with
renal disease defined as blood urea > 30 mg/dL or serum creatinine > 1.4 mg/dL
◦ Haemoglobin < 10 g/dL
◦ History of deep venous thrombosis, pulmonary embolus or cerebrovascular accident
◦ Known heart disease that is likely to be exacerbated by pregnancy
◦ History of, or suspected cervical carcinoma, endometrial carcinoma or breast carcinoma. A
normal Pap smear result was required for women aged ≥ 21 years
◦ Current alcohol abuse defined as > 14 drinks/week or binge drinking
◦ Enrolled into other investigative studies that require medications, prescribe the study
medications, limit intercourse or otherwise prevent compliance with the protocol
◦ Anticipate taking longer than a 1-month break during the protocol were not enrolled
◦ Other medications known to affect reproductive function or metabolism. These medications
included oral contraceptives, GnRH agonists and antagonists, antiandrogens, gonadotropins, antiobesity
drugs, Chinese herbal formula, antidiabetic drugs such as metformin and thiazolidinediones, somatostatin,
diazoxide, angiotensin-converting-enzyme inhibitors and calcium channel blockers. Washout period on all
these medications was 2 months
◦ Suspected adrenal or ovarian tumour-secreting androgens
◦ Couples with previous sterilisation procedures (vasectomy, tubal ligation), which had been
reversed. The prior procedure may affect study outcomes, and people with both a reversed sterilisation
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procedure and PCOS were rare enough that exclusion should not adversely affect recruitment
◦ Undergone a bariatric surgery procedure in past 12 months and in a period of acute weight loss or
have been advised against pregnancy by their bariatric surgeon
◦ Untreated poorly controlled hypertension defined as a systolic blood pressure > 160 mmHg or a
diastolic > 100 mmHg obtained on 2 measures obtained at least 60 minutes apart
◦ Known congenital adrenal hyperplasia
Interventions 2 different acupuncture regimens
Letrozole
Placebo
Outcomes Live birth rate, ovulation rate, ongoing pregnancy rate, multiple pregnancy rate, miscarriage rate, hormonal
profile, metabolic profile, adverse effect profile
Starting date 1 August 2018
Contact information Ma Hongxia, the First Affiliated Hospital of Guangzhou Medical University
Notes
NCT02491333
Trial name or title The RCT of acupuncture on PCOS combined with IR
Methods Randomised controlled trial





Outcomes HOMA-IR, HOMA-B, AUCglu, menstrual frequency, body composition, metabolic profile, hormonal pro-
file, questionnaires, side effect profile, expectation and credibility of treatment, AUCins, ovulation rate
Starting date August 2015
Contact information Hongxia Ma, The First Affiliated Hospital of Guangzhou Medical University
Notes
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NCT02647827
Trial name or title Acupuncture or metformin for insulin resistance in women with polycystic ovary syndrome: a randomized
controlled trial
Methods Randomised controlled trial





• Changes from baseline to after 4 months in HOMA-IR
• Changes from baseline to after 4 months of treatment in HbA1c
• Changes from baseline to after 4 months of treatment in insulin response to glucose during the oral
glucose tolerance test
Secondary outcomes
• Changes from baseline to after 4 months and again 4 months after last treatment in secondary
metabolic measures
• Changes from baseline to after 4 months and again 4 months after last treatment gene expression and
DNA methylation profiles related to insulin sensitivity in fat, muscle and endometrial tissue biopsies, and
biomarkers in whole blood
• Changes from baseline to after 4 months and again 4 months after last treatment in menstrual pattern
• Changes from baseline to after 4 months and again 4 months after last treatment in circulating
reproductive hormones
• Changes from baseline to after 4 months and again 4 months after last treatment in women’s health-
related quality of life
• Changes from baseline to after 4 months and again 4 months after last treatment in women’s
symptoms of anxiety and depression
• Changes from baseline to after 4 months and again 4 months after last treatment in women’s dieting
and eating patterns
• Cost-effectiveness of the different treatments throughout the study
Starting date December 2015
Contact information Elisabet Stener-Victorin, PhD, Karolinska Institutet
Notes Estimated study completion date: December 2019
NCT02653911
Trial name or title Efficacy of acupuncture on menstrual frequency in women with polycystic ovary syndrome: protocol for a
randomized, controlled trial
Methods Randomised controlled trial
Participants 172 participants diagnosed with polycystic ovary syndrome
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• Proportion of participants with ≥ 50% increase from baseline in monthly menstrual frequency
Secondary outcomes
• Difference in anthropometrics
• Serum hormone level
• Ovarian morphology
• Anxiety and depression
• Quality of life from baseline to after 12 weeks’ intervention and to 12 weeks postintervention follow-up
Starting date July 2018
Contact information Zhou Jing, Department of Acupuncture, Guang’anmen Hospital of China Academy of Chinese Medical
Sciences
Notes Estimated study completion date: June 2020
ALT: alanine aminotransferase; AST: aspartate aminotransferase; AUCglu: area under the glucose curve; AUCins: area under the insulin
curve; BMI: body-mass index; E2: 17β-estradiol; FSH: follicle-stimulating hormone; GnRH: gonadotropin-releasing hormone;
HbA1c: glycated haemoglobin; HOMA-B: homeostatic model assessment for β-cell function; HOMA-IR: homeostatic model
assessment for insulin resistance; LH: luteinising hormone; PCOS: polycystic ovarian syndrome; TSH: thyroid-stimulating hormone.
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D A T A A N D A N A L Y S E S
Comparison 1. True acupuncture versus sham acupuncture




participants Statistical method Effect size
1 Live birth rate 1 926 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.76, 1.24]
2 Multiple pregnancy rate 1 926 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.33, 2.45]
3 Ovulation rate 2 Std. Mean Difference (Fixed, 95% CI) 0.02 [-0.15, 0.19]
4 Clinical pregnancy rate 3 1117 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.82, 1.29]
5 Restored regular menstrual
period
1 141 Mean Difference (IV, Fixed, 95% CI) -312.09 [-344.59, -
279.59]
6 Miscarriage rate 1 926 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.77, 1.56]
7 Adverse events 3 1230 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [1.02, 1.31]
Comparison 2. Low-frequency electroacupuncture versus physical exercise or no intervention




participants Statistical method Effect size
1 Restored regular menstrual
period








1 31 Mean Difference (IV, Fixed, 95% CI) 0.37 [0.21, 0.53]
2 Adverse events 1 201 Risk Ratio (M-H, Fixed, 95% CI) 4.46 [0.77, 25.78]
2.1 Haematoma 1 67 Risk Ratio (M-H, Fixed, 95% CI) 7.21 [0.39, 134.32]
2.2 Dizziness 1 67 Risk Ratio (M-H, Fixed, 95% CI) 3.09 [0.13, 73.20]
2.3 Nausea 1 67 Risk Ratio (M-H, Fixed, 95% CI) 3.09 [0.13, 73.20]
Comparison 3. True acupuncture versus relaxation




participants Statistical method Effect size
1 Ovulation rate 1 28 Mean Difference (IV, Fixed, 95% CI) 0.35 [0.14, 0.56]
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Comparison 4. True acupuncture versus clomiphene




participants Statistical method Effect size
1 Restored regular menstrual
period
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Restored menstruation at
the end of treatment
1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.64 [0.94, 2.85]
1.2 Restored menstruation 1
month after end of treatment
1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [1.03, 2.19]
2 Adverse events 1 120 Risk Ratio (M-H, Fixed, 95% CI) 1.33 [0.30, 5.83]
2.1 Haematoma 1 60 Risk Ratio (M-H, Fixed, 95% CI) 7.0 [0.38, 129.93]
2.2 Gastrointestinal adverse
effects
1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 4.00]
Comparison 5. True acupuncture versus Diane-35




participants Statistical method Effect size
1 Ovulation rate 1 68 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.87, 2.42]
2 Adverse events 2 360 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.25, 1.99]
2.1 Haematoma 2 120 Risk Ratio (M-H, Fixed, 95% CI) 3.74 [0.43, 32.53]
2.2 Nausea 1 52 Risk Ratio (M-H, Fixed, 95% CI) 0.19 [0.01, 3.69]
2.3 Gastrointestinal upset 1 68 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.01, 7.47]
2.4 Headache 1 52 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.01, 7.26]
2.5 Weight gain 1 68 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.01, 7.47]
Analysis 1.1. Comparison 1 True acupuncture versus sham acupuncture, Outcome 1 Live birth rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture
Outcome: 1 Live birth rate
Study or subgroup True acupuncture Sham acupuncture Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wu 2017 100/458 105/468 100.0 % 0.97 [ 0.76, 1.24 ]
Total (95% CI) 458 468 100.0 % 0.97 [ 0.76, 1.24 ]
Total events: 100 (True acupuncture), 105 (Sham acupuncture)
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours true acupuncture Favours sham acupuncture
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Analysis 1.2. Comparison 1 True acupuncture versus sham acupuncture, Outcome 2 Multiple pregnancy
rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture
Outcome: 2 Multiple pregnancy rate
Study or subgroup True acupuncture Sham acupuncture Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wu 2017 7/458 8/468 100.0 % 0.89 [ 0.33, 2.45 ]
Total (95% CI) 458 468 100.0 % 0.89 [ 0.33, 2.45 ]
Total events: 7 (True acupuncture), 8 (Sham acupuncture)
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours true acupuncture Favours sham acupuncture
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Analysis 1.3. Comparison 1 True acupuncture versus sham acupuncture, Outcome 3 Ovulation rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture











IV,Fixed,95% CI IV,Fixed,95% CI
Pastore 2011 -0.1157 (0.2187) 15.5 % -0.12 [ -0.54, 0.31 ]
Wu 2017 0.04243 (0.0938) 84.5 % 0.04 [ -0.14, 0.23 ]
Total (95% CI) 100.0 % 0.02 [ -0.15, 0.19 ]
Heterogeneity: Chi2 = 0.44, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.84)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours true acupuncture Favours sham acupuncture
Analysis 1.4. Comparison 1 True acupuncture versus sham acupuncture, Outcome 4 Clinical pregnancy
rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture
Outcome: 4 Clinical pregnancy rate
Study or subgroup True acupuncture Sham acupuncture Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lim 2014 5/98 0/48 0.6 % 5.44 [ 0.31, 96.48 ]
Pastore 2011 (1) 4/20 3/25 2.4 % 1.67 [ 0.42, 6.60 ]
Wu 2017 107/458 111/468 97.1 % 0.99 [ 0.78, 1.24 ]
Total (95% CI) 576 541 100.0 % 1.03 [ 0.82, 1.29 ]
Total events: 116 (True acupuncture), 114 (Sham acupuncture)
Heterogeneity: Chi2 = 1.89, df = 2 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours sham acupuncture Favours true acupuncture
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(1) Published paper says ’pregnancy’; this was as reported by participants and not defined
Analysis 1.5. Comparison 1 True acupuncture versus sham acupuncture, Outcome 5 Restored regular
menstrual period.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture
Outcome: 5 Restored regular menstrual period





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Lim 2014 (1) 93 -266.22 (158.98) 48 45.87 (12.24) 100.0 % -312.09 [ -344.59, -279.59 ]
Total (95% CI) 93 48 100.0 % -312.09 [ -344.59, -279.59 ]
Heterogeneity: not applicable
Test for overall effect: Z = 18.82 (P < 0.00001)
Test for subgroup differences: Not applicable
-500 -250 0 250 500
Favours true acupuncture Favours sham acupuncture
(1) This figure illustrates the change in days between menstruation before and after treatment. A negative value indicates shorter period between menstruation.
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Analysis 1.6. Comparison 1 True acupuncture versus sham acupuncture, Outcome 6 Miscarriage rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture
Outcome: 6 Miscarriage rate
Study or subgroup True acupuncture Sham acupuncture Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wu 2017 57/458 53/468 100.0 % 1.10 [ 0.77, 1.56 ]
Total (95% CI) 458 468 100.0 % 1.10 [ 0.77, 1.56 ]
Total events: 57 (True acupuncture), 53 (Sham acupuncture)
Heterogeneity: not applicable
Test for overall effect: Z = 0.53 (P = 0.60)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours true acupuncture Favours sham acupuncture
Analysis 1.7. Comparison 1 True acupuncture versus sham acupuncture, Outcome 7 Adverse events.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 1 True acupuncture versus sham acupuncture
Outcome: 7 Adverse events
Study or subgroup True acupuncture Sham acupuncture Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lim 2014 0/98 0/48 Not estimable
Pastore 2011 1/40 0/44 0.2 % 3.29 [ 0.14, 78.59 ]
Wu 2017 273/500 237/500 99.8 % 1.15 [ 1.02, 1.30 ]
Total (95% CI) 638 592 100.0 % 1.16 [ 1.02, 1.31 ]
Total events: 274 (True acupuncture), 237 (Sham acupuncture)
Heterogeneity: Chi2 = 0.42, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 2.33 (P = 0.020)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours true acupuncture Favours sham acupuncture
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Analysis 2.1. Comparison 2 Low-frequency electroacupuncture versus physical exercise or no intervention,
Outcome 1 Restored regular menstrual period.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 2 Low-frequency electroacupuncture versus physical exercise or no intervention
Outcome: 1 Restored regular menstrual period





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency electroacupuncture versus physical exercise
Jedel 2011 21 0.33 (0.37) 19 0.11 (0.36) 100.0 % 0.22 [ -0.01, 0.45 ]
Subtotal (95% CI) 21 19 100.0 % 0.22 [ -0.01, 0.45 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.90 (P = 0.057)
2 Low-frequency electroacupuncture versus no intervention
Jedel 2011 21 0.33 (0.37) 10 -0.04 (0.07) 100.0 % 0.37 [ 0.21, 0.53 ]
Subtotal (95% CI) 21 10 100.0 % 0.37 [ 0.21, 0.53 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.42 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.11, df = 1 (P = 0.29), I2 =10%
-1 -0.5 0 0.5 1
Favours physical exercise Favours acupuncture
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Analysis 2.2. Comparison 2 Low-frequency electroacupuncture versus physical exercise or no intervention,
Outcome 2 Adverse events.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 2 Low-frequency electroacupuncture versus physical exercise or no intervention
Outcome: 2 Adverse events
Study or subgroup Electroacupuncture Exercise Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Haematoma
Jedel 2011 3/33 0/34 33.3 % 7.21 [ 0.39, 134.32 ]
Subtotal (95% CI) 33 34 33.3 % 7.21 [ 0.39, 134.32 ]
Total events: 3 (Electroacupuncture), 0 (Exercise)
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
2 Dizziness
Jedel 2011 1/33 0/34 33.3 % 3.09 [ 0.13, 73.20 ]
Subtotal (95% CI) 33 34 33.3 % 3.09 [ 0.13, 73.20 ]
Total events: 1 (Electroacupuncture), 0 (Exercise)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.49)
3 Nausea
Jedel 2011 1/33 0/34 33.3 % 3.09 [ 0.13, 73.20 ]
Subtotal (95% CI) 33 34 33.3 % 3.09 [ 0.13, 73.20 ]
Total events: 1 (Electroacupuncture), 0 (Exercise)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.49)
Total (95% CI) 99 102 100.0 % 4.46 [ 0.77, 25.78 ]
Total events: 5 (Electroacupuncture), 0 (Exercise)
Heterogeneity: Chi2 = 0.21, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.095)
Test for subgroup differences: Chi2 = 0.20, df = 2 (P = 0.90), I2 =0.0%
0.01 0.1 1 10 100
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Analysis 3.1. Comparison 3 True acupuncture versus relaxation, Outcome 1 Ovulation rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 3 True acupuncture versus relaxation
Outcome: 1 Ovulation rate





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Johansson 2013 16 0.76 (0.27) 12 0.41 (0.28) 100.0 % 0.35 [ 0.14, 0.56 ]
Total (95% CI) 16 12 100.0 % 0.35 [ 0.14, 0.56 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.32 (P = 0.00089)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
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Analysis 4.1. Comparison 4 True acupuncture versus clomiphene, Outcome 1 Restored regular menstrual
period.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 4 True acupuncture versus clomiphene
Outcome: 1 Restored regular menstrual period
Study or subgroup Acupuncture Clomiphene Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Restored menstruation at the end of treatment
Du 2011 18/30 11/30 100.0 % 1.64 [ 0.94, 2.85 ]
Subtotal (95% CI) 30 30 100.0 % 1.64 [ 0.94, 2.85 ]
Total events: 18 (Acupuncture), 11 (Clomiphene)
Heterogeneity: not applicable
Test for overall effect: Z = 1.74 (P = 0.081)
2 Restored menstruation 1 month after end of treatment
Du 2011 24/30 16/30 100.0 % 1.50 [ 1.03, 2.19 ]
Subtotal (95% CI) 30 30 100.0 % 1.50 [ 1.03, 2.19 ]
Total events: 24 (Acupuncture), 16 (Clomiphene)
Heterogeneity: not applicable
Test for overall effect: Z = 2.09 (P = 0.036)
Test for subgroup differences: Chi2 = 0.06, df = 1 (P = 0.80), I2 =0.0%
0.01 0.1 1 10 100
Favours true acupuncture Favours clomiphene
67Acupuncture for polycystic ovarian syndrome (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.2. Comparison 4 True acupuncture versus clomiphene, Outcome 2 Adverse events.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 4 True acupuncture versus clomiphene
Outcome: 2 Adverse events
Study or subgroup Acupuncture Clomiphene Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Haematoma
Du 2011 3/30 0/30 16.7 % 7.00 [ 0.38, 129.93 ]
Subtotal (95% CI) 30 30 16.7 % 7.00 [ 0.38, 129.93 ]
Total events: 3 (Acupuncture), 0 (Clomiphene)
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
2 Gastrointestinal adverse effects
Du 2011 0/30 2/30 83.3 % 0.20 [ 0.01, 4.00 ]
Subtotal (95% CI) 30 30 83.3 % 0.20 [ 0.01, 4.00 ]
Total events: 0 (Acupuncture), 2 (Clomiphene)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.29)
Total (95% CI) 60 60 100.0 % 1.33 [ 0.30, 5.83 ]
Total events: 3 (Acupuncture), 2 (Clomiphene)
Heterogeneity: Chi2 = 2.78, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 0.38 (P = 0.70)
Test for subgroup differences: Chi2 = 2.77, df = 1 (P = 0.10), I2 =64%
0.01 0.1 1 10 100
Favours acupuncture Favours clomiphene
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Analysis 5.1. Comparison 5 True acupuncture versus Diane-35, Outcome 1 Ovulation rate.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 5 True acupuncture versus Diane-35
Outcome: 1 Ovulation rate
Study or subgroup Acupuncture Diane-35 Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Jin 2016 20/35 13/33 100.0 % 1.45 [ 0.87, 2.42 ]
Total (95% CI) 35 33 100.0 % 1.45 [ 0.87, 2.42 ]
Total events: 20 (Acupuncture), 13 (Diane-35)
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours acupuncture Favours Diane-35
Analysis 5.2. Comparison 5 True acupuncture versus Diane-35, Outcome 2 Adverse events.
Review: Acupuncture for polycystic ovarian syndrome
Comparison: 5 True acupuncture versus Diane-35
Outcome: 2 Adverse events
Study or subgroup Acupuncture Diane-35 Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Haematoma
Cao 2017 2/27 0/25 6.3 % 4.64 [ 0.23, 92.24 ]
Jin 2016 1/35 0/33 6.2 % 2.83 [ 0.12, 67.19 ]
Subtotal (95% CI) 62 58 12.5 % 3.74 [ 0.43, 32.53 ]
Total events: 3 (Acupuncture), 0 (Diane-35)
Heterogeneity: Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 1.20 (P = 0.23)
2 Nausea
Cao 2017 0/27 2/25 31.4 % 0.19 [ 0.01, 3.69 ]
Subtotal (95% CI) 27 25 31.4 % 0.19 [ 0.01, 3.69 ]
0.01 0.1 1 10 100
Favours acupuncture Favours Diane-35
(Continued . . . )
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(. . . Continued)
Study or subgroup Acupuncture Diane-35 Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 0 (Acupuncture), 2 (Diane-35)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
3 Gastrointestinal upset
Jin 2016 0/35 1/33 18.7 % 0.31 [ 0.01, 7.47 ]
Subtotal (95% CI) 35 33 18.7 % 0.31 [ 0.01, 7.47 ]
Total events: 0 (Acupuncture), 1 (Diane-35)
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
4 Headache
Cao 2017 0/27 1/25 18.8 % 0.31 [ 0.01, 7.26 ]
Subtotal (95% CI) 27 25 18.8 % 0.31 [ 0.01, 7.26 ]
Total events: 0 (Acupuncture), 1 (Diane-35)
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
5 Weight gain
Jin 2016 0/35 1/33 18.7 % 0.31 [ 0.01, 7.47 ]
Subtotal (95% CI) 35 33 18.7 % 0.31 [ 0.01, 7.47 ]
Total events: 0 (Acupuncture), 1 (Diane-35)
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
Total (95% CI) 186 174 100.0 % 0.70 [ 0.25, 1.99 ]
Total events: 3 (Acupuncture), 5 (Diane-35)
Heterogeneity: Chi2 = 3.79, df = 5 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.51)
Test for subgroup differences: Chi2 = 3.81, df = 4 (P = 0.43), I2 =0.0%
0.01 0.1 1 10 100
Favours acupuncture Favours Diane-35
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A P P E N D I C E S
Appendix 1. Cochrane Gynaecology and Fertility Group Specialised Register search strategy
Searched 22 May 2018
PROCITE platform
Keywords CONTAINS “polycystic ovary morphology” or “*Polycystic Ovary Syndrome” or “PCOS” or “Oligo-amenorrhea” or
“oligoamenorrhea” or “oligoanovulatory” or “oligohypomenorrhea” or “amenorrhea” or “amenorrhoea” or “hirsutism” or Title CON-
TAINS “polycystic ovary morphology” or “*Polycystic Ovary Syndrome” or “PCOS” or “Oligo-amenorrhea” or “oligoamenorrhea” or
“oligoanovulatory” or “oligohypomenorrhea” or “amenorrhea” or “amenorrhoea” or “hirsutism”
AND
Keywords CONTAINS “acupoint” or “acupressure” or “acupressure-acupuncture therapy” or “acupuncture” or “electro-acupuncture”
or “electroacupuncture” or “moxibustion” or “Tui Na” or Title CONTAINS “acupoint” or “acupressure” or “acupressure-acupuncture
therapy” or “acupuncture” or “electro-acupuncture” or “electroacupuncture” or “moxibustion” or “Tui Na” (36 hits)
Appendix 2. CENTRAL Register of Studies Online (CRSO) search strategy
Searched 22 May 2018
Web platform
#1 MESH DESCRIPTOR Polycystic Ovary Syndrome EXPLODE ALL TREES 1170
#2 (polycystic ovar*):TI,AB,KY 2370
#3 (PCOS or PCOD):TI,AB,KY 1928
#4 (stein-leventhal syndrome):TI,AB,KY 3
#5 hirsut*:TI,AB,KY 591
#6 #1 OR #2 OR #3 OR #4 OR #5 2924







#14 (acup* point*):TI,AB,KY 2197
#15 (shiatsu or tui na):TI,AB,KY 28
#16 shu:TI,AB,KY 258
#17 acupressure:TI,AB,KY 763
#18 (trigger adj3 point*):TI,AB,KY 682
#19 #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 14633
#20 #6 AND #19 74
Appendix 3. MEDLINE search strategy
Searched from 1946 to 22 May 2018
Ovid Platform
1 exp Polycystic Ovary Syndrome/ (12729)
2 polycystic ovar$.tw. (14304)
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11 acupuncture.tw. (19129)
12 exp Acupuncture/ (1501)






18 acup$ point$.tw. (1544)
19 (shiatsu or tui na).tw. (108)
20 shu.tw. (759)
21 acupressure.tw. (894)
22 (trigger adj3 point$).tw. (1905)
23 or/11-22 (38977)
24 randomized controlled trial.pt. (462119)




29 clinical trials as topic.sh. (183822)
30 randomly.ab. (291200)
31 trial.ti. (183145)
32 (crossover or cross-over or cross over).tw. (76588)
33 or/24-32 (1211060)
34 exp animals/ not humans.sh. (4462498)
35 33 not 34 (1115554)
36 10 and 23 and 35 (75)
Appendix 4. Embase search strategy
Searched from 1980 to 22 May 2018
Ovid Platform
1 exp ovary polycystic disease/ (23430)
2 polycystic ovar$.tw. (19736)




7 exp “amenorrhea and oligomenorrhea”/ or exp secondary amenorrhea/ or exp amenorrhea/ or exp primary amenorrhea/ (27466)









17 acup$ point$.tw. (2359)
18 (shiatsu or tui na).tw. (154)
19 shu.tw. (1578)
20 acupressure.tw. (1187)
21 (trigger adj3 point$).tw. (2894)
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22 or/12-21 (56901)
23 11 and 22 (320)
24 Clinical Trial/ (964217)
25 Randomized Controlled Trial/ (499723)
26 exp randomization/ (78253)
27 Single Blind Procedure/ (31333)
28 Double Blind Procedure/ (147013)
29 Crossover Procedure/ (55360)
30 Placebo/ (311217)
31 Randomi?ed controlled trial$.tw. (181155)
32 Rct.tw. (28426)
33 random allocation.tw. (1779)
34 randomly allocated.tw. (29590)
35 allocated randomly.tw. (2315)
36 (allocated adj2 random).tw. (796)
37 Single blind$.tw. (20811)
38 Double blind$.tw. (181979)
39 ((treble or triple) adj blind$).tw. (775)
40 placebo$.tw. (267842)
41 prospective study/ (448348)
42 or/24-41 (1902190)
43 case study/ (54421)
44 case report.tw. (353224)
45 abstract report/ or letter/ (1037032)
46 or/43-45 (1436046)
47 42 not 46 (1854050)
48 23 and 47 (129)
Appendix 5. PsycINFO search strategy
Searched from 1806 to 22 May 2018
Ovid Platform
1 exp endocrine sexual disorders/ (1133)
2 polycystic ovar$.tw. (375)













16 acup$ point$.tw. (147)
17 acupuncture.tw. (1823)
18 (shiatsu or tui na).tw. (22)
19 shu.tw. (202)
20 acupressure.tw. (160)
21 (trigger adj3 point$).tw. (322)
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22 or/11-21 (3398)
23 10 and 22 (2)
Appendix 6. AMED (Allied and Complementary Medicine) search strategy
Searched from 1985 to 22 May 2018
Ovid Platform
1 exp ovarian disease/ (220)
2 polycystic ovar$.tw. (72)









12 exp acupuncture/ (3302)






19 exp Moxibustion/ (543)
20 acup$ point$.tw. (646)
21 (shiatsu or tui na).tw. (341)
22 shu.tw. (91)
23 acupressure.tw. (395)
24 (trigger adj3 point$).tw. (472)
25 or/12-24 (11584)
26 11 and 25 (40)
Appendix 7. CNKI search strategy
Searched December 2010 to May 2018
Web platform
1 polycystic ovary syndrome
2 polycystic ovary





8 traditional Chinese medicine
9 traditional Chinese medicine combined with western medicine
10 #4~#9/or
11 random*
12 #3 and #10 and #11
All of the search terms were translated into Chinese terms when we conduct the searches in Chinese databases.
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Appendix 8. SinoMed (CBM) search strategy
Searched 2010 to November 2015
Web platform
Title or Keywords or Abstract CONTAINS: “random” AND (“polycystic ovarian syndrome” OR “polycystic ovaries”) AND (“needling”
OR “acupuncture” OR “electroacupuncture” OR “traditional Chinese medicine” OR “traditional medicine” OR “traditional Chinese
medicine combined with western medicine”)
All of the search terms were translated into Chinese terms when we conduct the searches in Chinese databases.
Appendix 9. Chinese VIP database search strategy
Searched 2010 to May 2018
Web platform
Keyword and Title CONTAINS “polycystic ovarian syndrome” OR “polycystic ovaries” AND ((Keyword and Title CONTAINS
“needling” OR “electroacupuncture” OR “acupuncture” OR “traditional Chinese medicine” OR “traditional medicine” OR “tradi-
tional Chinese medicine combined with western medicine”) OR (Abstract CONTAINS needling“ OR ”electroacupuncture“ OR
”acupuncture“ OR ”traditional Chinese medicine“ OR ”traditional medicine“ OR ”traditional Chinese medicine combined with west-
ern medicine“)) AND Full text CONTAINS ”random“
All of the search terms were translated into Chinese terms when we conduct the searches in Chinese databases.
Appendix 10. Ongoing trials
Ongoing trials were also searched in:
• ClinicalTrials.gov
• World Health Organization International Trials Registry
• Australian and New Zealand Clinical Trial Registry
W H A T ’ S N E W
Date Event Description
24 May 2019 New search has been performed Three studies included in this update (Cao 2017;




24 May 2019 New citation required but conclusions have not changed The updated review now has included three new studies
however conclusions have not changed
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C O N T R I B U T I O N S O F A U T H O R S
DL: for the protocol: protocol development and revision; topic conception and methodological aspects; protocol review and final proof.
For the systematic review: study selection, methodology, adequacy of treatment, data analysis, interpretation of findings and writing
the review.
RN: for the systematic review of the English literature: study selection, methodology, adequacy of treatment, data extraction, data
analysis, interpretation of findings and writing the review.
GZ: for the systematic review of the Chinese literature: study selection, methodology, adequacy of treatment, data extraction, data
analysis, interpretation of findings and writing the review.
LC: for the protocol: topic conception; protocol final proof. For the systematic review: final proof; provided expert advice on gynaecology
for the studies found.
HC: for the systematic review: dispute resolution for study selection, adequacy of treatment and revision, and review of final interpre-
tations of findings and provided expert advice on acupuncture treatment in the studies found.
D E C L A R A T I O N S O F I N T E R E S T
The primary author of one included study is also the primary author (DL) of this review (Lim 2014). In order to minimise any potential
risk of bias during the review process, two review authors (RN, GZ) independently extracted data using a piloted data extraction form.
All studies were then assessed independently and any dispute was resolved by a third independent review author (HC).
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• South Western Sydney Clinical School Scholarship, University of New South Wales, Australia, Australia.
CED Lim received the postgraduate scholarship from South Western Sydney Clinical School, Faculty of Medicine, University of New
South Wales (2008-10) to support the work in this project
D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W
Authors: we added Dr Wei Chen and Dr Lisa N Cheng to the authors, as data extractors and review manuscript developers at the 2015
version of this systematic review.
Authors: Dr Wei Chen, Prof A O’Sullivan and Prof Felix Wong stepped down and were replaced by Dr Rachel Ng, Dr Ke Xu and Ms
Nini Chen as data extractors and review manuscript developers at the second edition of this systematic review.
Authors: Dr Ke Xu and Ms Nini Chen stepped down and were replaced by Dr George Shengxi Zhang and Dr Hui Chen as data
extractors and review manuscript developers at the third edition of this systematic review.
Methods: in the third edition of the systematic review we changed multiple pregnancy from a secondary outcome to a primary outcome.
Methods: we added adverse events as a secondary outcome in the review.
Methods: we added lifestyle intervention as a comparison as per advice of referee.
Methods: we described subgroup analysis in a more concise way, as per advice of referee.
Methods: we changed the definition of the outcome restored regular menstrual period to ’as defined by authors’.
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Methods: we were unable to access Chinese BioMedical Literature Database (CBM) for this version of the review and therefore have
not been able to update the search for this database
Methods: we changed measurement of dichotomous outcomes from Mantel Haenszel odds ratio to risk ratio.
Methods: we changed the definition of Live birth rate from “Live birth rate per couple (in studies or study subgroups of women seeking
a live birth)” to “Live birth rate (defined as delivery of live foetus after 20 completed weeks of gestation) - for women seeking fertility”
Methods: we changed the definition of Clinical pregnancy rate from ”Clinical pregnancy rate per woman“ to ”Clinical pregnancy rate
(defined as evidence of gestational sac or foetal heart motion, confirmed with ultrasound).“
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Acupuncture Therapy; Clomiphene [therapeutic use]; Electroacupuncture; Estrogen Antagonists [therapeutic use]; Exercise Therapy;
Menstruation; Ovulation; Polycystic Ovary Syndrome [∗therapy]; Randomized Controlled Trials as Topic; Relaxation Therapy
MeSH check words
Female; Humans; Pregnancy
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